[{"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1348-2019", "product_description": "Children's Mapap Acetaminophen Liquid, Fever reducer, Pain reliever, Alcohol free, Aspirin free, Cherry flavored, acetaminophen 160 mg per 5 mL, a) 4 FL. oz. (118 mL) bottle, NDC 0904-1985-20, b) One Pint (473 mL) bottle, NDC: 0904-1985-16, Distributed by Major Pharmaceuticals, Livonia MI 48152.", "product_quantity": "2,646,228 bottles", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: a) 17E003; 17E038, Exp. 05/2019; 17F002; 17F005; 17F007; 17F025, Exp. 06/2019; 17G014, Exp. 07/2019; 17H015, Exp. 08/2019; 17J004; 17J006; 17J016, Exp. 09/2019; 17K008; 17K013; 17K021; 17K027, Exp. 10/2019; 17L021, Exp. 11/2019; 17M032, Exp. 12/2019; 18A023; 18A039, Exp. 01/2020; 18B007; 18B030; 18B037, Exp. 02/2020; 18C017; 18C026, Exp. 03/2020; 18D003; 18D034, Exp. 04/2020; 18E027; 18E033, Exp. 05/2020; 18F024; 18F033, Exp. 06/2020; 18G001; 18G023, Exp. 07/2020; 18J008; 18J009;   18J017; 18J027, Exp. 09/2020; 18K013; 18K014; 18K028, Exp. 10/2020.    b) 17E006; 17E008, Exp. 05/2019; 17G001; 17G008;17G025, Exp. 07/2019; 17J022, Exp. 09/2019; 17K001; 17K007; 17K007A, Exp. 10/2019; 17L014, 17L034, Exp. 11/2019; 18A007; 18A007A, Exp. 01/2020; 18A025; 18A036, Exp.  01/2020; 18B018; 18B033; 18B034, Exp. 02/2020; 18D032; 18D035, Exp. 04/2020; 18E006; 18E035; 18E036, Exp. 05/2020; 18F033; 18F034, Exp. 06/2020; 18G007; 18G019, Exp. 07/2020; 18H008; 18H009; 18H025, Exp. 08/2020; 19A002, Exp. 01/2021."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1430-2016", "product_description": "5 mcg/mL HYDROmorphone HCl and 0.1% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride, 200 mL in 250 mL Hospira LifeCare Bag, Service Code 2H8233, Rx Only,  Compounded by PharMEDium Services, LLC, Memphis, TN 36141, NDC 61553-233-54", "product_quantity": "90 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Lot Number 160730064M , Exp. Date 6/2/2016 ;  Lot Number 160800057M , Exp. Date 6/9/2016 ;  Lot Number 160820113M , Exp. Date 6/11/2016 ;  Lot Number 160960142M , Exp. Date 6/26/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Levittown", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82889", "recalling_firm": "Torrent Pharma Inc", "address_1": "2091 Hartel Ave", "address_2": "N/A", "postal_code": "19057-4506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 9 distributors, direct accounts and relabelers who may have further distributed the product throughout the United States.", "recall_number": "D-1376-2019", "product_description": "Hydrocortisone Acetate Suppositories, 25 mg, Rx Only, For rectal administration, a) 12 Adult Suppositories per carton, NDC: 59741-301-12, b) 24 Adult Suppositories per carton, NDC: 59741-301-24, Manufactured by Bio-Pharm Inc., Levittown PA 19057.", "product_quantity": "140,436 suppositories", "reason_for_recall": "cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).", "recall_initiation_date": "20190521", "center_classification_date": "20190613", "termination_date": "20201006", "report_date": "20190619", "code_info": "Lot #s: a) 17L010, Exp. 11/2019; 18D018, Exp. 04/2020; 18F022; 18F022A, Exp. 06/2020.     b) 17L019; 17L026, Exp. 11/2019; 18B005, Exp. 02/2020; 18D006, 18D012; 18D022, Exp. 04/2020; 18K006, Exp. 10/2020."}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA065259"], "brand_name": ["CEFDINIR"], "generic_name": ["CEFDINIR"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-722", "68180-723"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFDINIR"], "rxcui": ["309054", "476576"], "spl_id": ["b32b7bfb-4770-4da0-8c48-684233cd10c9"], "spl_set_id": ["7490df67-56c0-4a1c-8533-2107f3e8aea5"], "package_ndc": ["68180-722-20", "68180-722-10", "68180-722-04", "68180-722-05", "68180-723-20", "68180-723-10", "68180-723-04", "68180-723-05"], "is_original_packager": [true], "upc": ["0368180723042"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["CI0FAO63WC"]}, "product_type": "Drugs", "event_id": "84196", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to major distributors/wholesalers throughout the United States.", "recall_number": "D-0306-2020", "product_description": "Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (NDC 68180-722-20), b) 100 mL bottle (NDC 68180-722-10), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA", "product_quantity": "a) 4074 bottles b) 30,300 bottles", "reason_for_recall": "Presence of Foreign substance: identified as a dead ant.", "recall_initiation_date": "20191101", "center_classification_date": "20191107", "termination_date": "20210304", "report_date": "20191113", "code_info": "Lot #: a) F900153, Exp 11/20; b) F802327, F802328, F802329, Exp 11/20"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0796-2019", "product_description": "Dr. King's SafeCare Rx Extravagant, 2 fl. oz. (59 mL), King Bio, Inc., 3 Westside Drive, Asheville, NC 28806 USA, UPC 357955233022, NDC 57955-2331-2", "product_quantity": "12 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lot: 040616O Exp. 04/19"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73472", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "US: Nationwide and Singapore", "recall_number": "D-0828-2016", "product_description": "Dextrose Injection, USP, 50%, Packaged as 500 mL in 1000 mL Bag, Rx only, Hospira, Inc., Lake Forest, IL  60045, NDC 0409-7936-19, Barcode (01) 0 030409 793619 9", "product_quantity": "4368 bags", "reason_for_recall": "Chemical Contamination: Potential for contamination of the products with an aromatic hydrocarbon resin.", "recall_initiation_date": "20160308", "center_classification_date": "20160421", "termination_date": "20171206", "report_date": "20160427", "code_info": "Lot # 52-002-JT, Exp 04/17"}, {"status": "Terminated", "city": "Naperville", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69152", "recalling_firm": "Martin Avenue Pharmacy, Inc.", "address_1": "1247 Rickert Dr", "address_2": "N/A", "postal_code": "60540-1008", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide", "recall_number": "D-0080-2015", "product_description": "Fentanyl injectable 2000 mcg/mL packaged in 30 mL or 60 mL syringes, Martin Avenue Pharmacy, 1247 Rickert Dr, Naperville, IL.", "product_quantity": "40 mL", "reason_for_recall": "Lack of Assurance of Sterility: Martin Avenue Pharmacy, Inc. is conducting a voluntary recall of all compounded sterile preparations within expiry. The recall is being initiated in connection with a recent FDA inspection due to observations associated with certain quality control procedures that present a risk to sterility assurance.", "recall_initiation_date": "20140827", "center_classification_date": "20141029", "termination_date": "20180531", "report_date": "20141105", "code_info": "Lot Number: 07292014@37, Exp 10/27/2014", "more_code_info": ""}, {"status": "Terminated", "city": "Nixa", "state": "MO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "67228", "recalling_firm": "Schindele Enterprises dba Midwest Wholesale", "address_1": "617 N Althea Ave", "address_2": "N/A", "postal_code": "65714-7432", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed to PA, IL, TX, IA, GA, CT, FL, CA, LA, NY, MD, NV, and WI", "recall_number": "D-1338-2014", "product_description": "Magic For Men, packaged in 1ct blister pack and 12-pill/bottle, 390 mg  Manufactured For: BTQ Ski, Inc., Chicago, IL 60638", "product_quantity": "59/1-ct blister pack,  97/12-ct bottles", "reason_for_recall": "Marketed Without an Approved NDA/ANDA: These dietary supplements contain undeclared sildenafil, an analogue of sildenafil, and/or tadalafil.", "recall_initiation_date": "20140109", "center_classification_date": "20140520", "termination_date": "20150203", "report_date": "20140528", "code_info": "12-ct.bottle, Lot GP808, Exp. 10/16, 1-ct. blister Lot BN030613, EXP 020615"}, {"status": "Terminated", "city": "Lynnwood", "state": "WA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA103362"], "brand_name": ["LEUKINE"], "generic_name": ["SARGRAMOSTIM"], "manufacturer_name": ["Partner Therapeutics, Inc."], "product_ndc": ["71837-5843"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["SARGRAMOSTIM"], "rxcui": ["208083", "315199"], "spl_id": ["4ad3993c-6c7f-4a33-8ead-a912636ff4a1"], "spl_set_id": ["bb9a3820-f31a-4dd9-bef4-97094c01a398"], "package_ndc": ["71837-5843-1", "71837-5843-5"], "is_original_packager": [true], "upc": ["0371837584354"], "nui": ["M0024696", "M0024695", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]", "Granulocyte-Macrophage Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["5TAA004E22"]}, "product_type": "Drugs", "event_id": "88164", "recalling_firm": "Partner Therapeutics Inc", "address_1": "2625 162nd St Sw", "address_2": "", "postal_code": "98087-3263", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to one government account (ASPR)", "recall_number": "D-0655-2021", "product_description": "LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5", "product_quantity": "32,260 vials", "reason_for_recall": "FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.", "recall_initiation_date": "20210623", "center_classification_date": "20210713", "termination_date": "20230207", "report_date": "20210721", "code_info": "Lot #: E8023E, exp. date 11/30/2022", "more_code_info": ""}, {"country": "United States", "city": "Aquebogue", "address_1": "311 West Lane", "reason_for_recall": "Non-Sterility: Customer complaints of mold in the product after use and handling due to the fact that the preservative used in the lots of Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution may not be effective through expiry.", "address_2": "P.O. Box 849", "product_quantity": "363,746 bottles.", "code_info": "Lot #: 11440, Exp 09/13, labeled for CVS; 11441, Exp 09/13, labeled for CVS; 12042, Exp 01/14, labeled for CVS and Wal-Mart ; 12103, Exp 02/15, labeled for Wal-Mart; 12203, Exp 05/15, labeled for CVS and Wal-Mart; 12207, Exp 05/15, labeled for Wal-Mart; 12293, Exp 08/15, labeled for Wal-Mart; 12352, Exp 09/15, labeled for CVS and Target; and 12356, Exp 09/15, labeled for CVS and Target.", "center_classification_date": "20131218", "distribution_pattern": "Nationwide", "state": "NY", "product_description": "Carboxymethylcellulose Sodium 0.5% Ophthalmic Solution, 1 FL OZ (30 mL) bottle, sold under the following labels: (a) CVS pharmacy brand LUBRICANT EYE DROPS FOR MILD TO MODERATE DRY EYE, Distributed by CVS Pharmacy, Inc., Woonsocket, RI 02895, UPC 0 50428 053357 7 and UPC 0 50428 27364 7; (b) equate brand Lubricant Eye Drops, Distributed by Wal-Mart Stores, Inc., Bentonville, AR 72716, UPC 6 81131 03420 3; and (c) up & up brand lubricant eye drops, Dist. by Target Corporation, Minneapolis, MN 55403, UPC 8 58961 79102 0.", "report_date": "20131225", "classification": "Class I", "openfda": {}, "recalling_firm": "Altaire Pharmaceuticals, Inc.", "recall_number": "D-375-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "66217", "termination_date": "20140930", "recall_initiation_date": "20130906", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ASPIRIN Tablet, 325 mg may be potentially mislabeled as    CHOLECALCIFEROL, Tablet, 400 units, NDC 00904582360, Pedigree: W002642, EXP: 6/4/2014.", "address_2": "", "product_quantity": "300 Tablets", "code_info": "ASPIRIN, Tablet, 325 mg has the following code    Pedigree: W002640, EXP: 6/4/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN Tablet, 325 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49348000123", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-582-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Ocala", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "75289", "recalling_firm": "Wells Pharmacy Network LLC", "address_1": "1210 SW 33rd Ave", "address_2": "N/A", "postal_code": "34474-2853", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0346-2017", "product_description": "Chorionic Gonadotropin (New York State), 11,000 unit Injectable Kit, Compounded by Wells Pharmacy, Ocala, FL", "product_quantity": "18 kits (number of vials per kit vary by prescription)", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20160921", "center_classification_date": "20170104", "termination_date": "20210702", "report_date": "20170111", "code_info": "All lot codes of product prepared between 02/22/2016 and 09/14/2016, within expiry.     Known kit lot code: 06072016@44, 07292016@92, 08092016@80, 09132016@33.  Known vial lot code: 04042016@30, 07222016@26, 04042016@30, 08252016@3"}, {"status": "Terminated", "city": "Asheville", "state": "NC", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "80601", "recalling_firm": "King Bio Inc.", "address_1": "3 Westside Dr", "address_2": "N/A", "postal_code": "28806-2846", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "U.S.A. Nationwide, Canada, and Australia.", "recall_number": "D-0906-2019", "product_description": "Safecare+ Southeast Regional Allergies Homeopathic Non-Drowsy Taste Free, Oral Spray, 1 fl oz (29.6 mL), UPC 357955834519, NDC 57955-8345-1", "product_quantity": "895 bottles", "reason_for_recall": "Microbial contamination", "recall_initiation_date": "20180720", "center_classification_date": "20190308", "termination_date": "20220119", "report_date": "20190320", "code_info": "Lots: 013017K Exp. 01/20; 080515A Exp. 08/18"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0973-2023", "product_description": "oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL, IV Bag, Rx only, Cental Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6042-1", "product_quantity": "3821 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-241662, Exp. 7/20/2023; 36-242725, Exp. 7/26/2023; 36-243607, Exp. 7/30/2023; 36-243837, 36-243838, Exp. 7/31/2023; 36-245517, 36-245523, 36-245525, 36-245662, Exp. 8/2/2023; 36-247254, 36-247255, Exp. 8/8/2023; 36-247983, Exp. 8/10/2023; 36-254917, Exp. 9/5/2023"}, {"status": "Terminated", "city": "Pomona", "state": "CA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["M018"], "brand_name": ["GOOD NEIGHBOR PHARMACY EYE DROPS ORIGINAL FORMULA", "SUNMARK EYE DROPS ORIGINAL FORMULA"], "generic_name": ["TETRAHYDROZOLINE HCL 0.05%", "TETRAHYDROZOLINE HCL"], "manufacturer_name": ["AmerisourceBergen Drug Corporation", "Strategic Sourcing Services LLC"], "product_ndc": ["24385-075", "49348-037"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TETRAHYDROZOLINE HYDROCHLORIDE"], "rxcui": ["1052943"], "spl_id": ["0cfa2cc7-bb82-af55-e063-6394a90a28f0", "0d295927-09c8-5b68-e063-6394a90a965f"], "spl_set_id": ["1e39e3a5-34fe-4e73-8f5c-219c4ef31bfb", "33efa7e9-4c3a-4d72-af31-c5e35095c2ff"], "package_ndc": ["24385-075-05", "49348-037-29", "48879-009-07", "62011-0102-1"], "is_original_packager": [true], "upc": ["0087701149757", "0010939167330", "070038470113", "761706165003", "041163251106", "060383736132", "032251004599", "087701149757", "180410000156", "041220947317", "052569134726", "725439933803", "075450296044", "011110385970", "057800196167", "041310620427", "041250829164", "070253966842", "041415010765", "321130700609", "771058101604", "015127000666", "720007780360", "010939167330", "669635240610", "036800036390", "015400034203", "690689006143"], "unii": ["0YZT43HS7D"]}, "product_type": "Drugs", "event_id": "69945", "recalling_firm": "K C Pharmaceuticals Inc", "address_1": "3201 Producer Way", "address_2": "", "postal_code": "91768-3916", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "U.S. Nationwide and Canada (Ontario).", "recall_number": "D-0320-2015", "product_description": "Eye Drops (Tetrahydrozoline HCl 0.05%), 0.5 FL OZ (15 mL) Bottles, Over the Counter. Labeled: a) Best Choice, DISTRIBUTED BY: VALU MERCHANDISERS, CO., 5000 KANSAS AVE, KANSAS CITY, KS 66106, 0 70038 47011 3; b) CVP, Distributed by Salado Sales, Inc., Temple, Texas 76503, UPC: 7 61706 16500 3; c) Equaline, DISTRIBUTED BY SUPERVALU INC. EDEN PRAIRIE, MN 55344, UPC: 0 41163 25110 6; d) exact, Prepared For/Prepare Pour: Loblaws Inc., Montreal H4N 3L4, Tonronto M4T 2S8, Calgary T2E 7S9, CANADA, Imported by/Importe par: Arrow OTC, Mississauga, ON L5N 2B8, UPC: 0 60383 73613 2; e) FAMILY wellness, Distributed by: Family Dollar Services, Inc., 10401 Monroe Rd., Matthews, NC 28105, UPC: 0 32251 00459 9; f) Good Neighbor Pharmacy, Distributed By: AmerisourceBergen 1300 Moris Drive, Chesterbrook, PA 19087, UPC: 0 87701 14975 7, NDC: 24385-075-05; g) GOODSENSE, Manufactured By: KC Pharmaceuticals, Pomona, CA 91768, UPC: 1 80410 00015 6, NDC: 48879-009-07; h) H-E-B, Made with Pride and Care for H-E-B, San Antonio, TX 78204, UPC: 0 41220 94731 7; i) Health Mart PHARMACY, Distributed by McKesson One Post STreet, San Francisco, CA 94104, UPC: 0 52569 13472 6, NDC: 62011-0102-1; j) healthy accents, Distributed by: DZA Brands, LLC, 2110 Executive Drive, Salisbury, NC 28147, UPC: 7 25439 93380 3; k) HyVee, Distributed by HY-VEE, Inc., 5820 Westown Parkway, West Des Moines, IA 50266, UPC: 0 75450 29604 4; l) Kroger, Distributed by The Kroger Co., Cincinnati, Ohio 45202, UPC: 0 11110 38597 0; m) life BRAND, Imported for SHOPPERS DRUG MART PHARMAPRIX, Toronto, M2J 4W8, UPC: 057800-19616-7; n) life BRAND, Importe pour: SHOPPERS DRUG MART PHARMAPRIX, Toronto, M2J 4W8, UPC: 0 57800 19616 7; o) LiveBetter, Distributed By Onpoint, Inc., 2 Paragon Drive, Montvale, NJ 07645, UPC: 0 41310 62042 7; p) meijer, Dist. By Meijer Distribution, Inc., 2929 Walker Ave NW, Grand Rapids, MI 49544, UPC: 0 41250 82916 4; q) Our Family, Distributed By: Nash Finch Company, NFC Brands, 7600 France Ave S, MPLS, MN, 55435, UPC: 0 70253 96684 2; r) Publix, Distributed by Publix Super Markets, Inc., 3300 Publix Corporate Parkway, Lakeland, FL 33811, UPC: 0 41415 01076 5; s) Redness Relief, Distributed by: Safeway Inc., P.O. BOX 99, PLEASANTON, CA 94566-0009, UPC: 3 21130 70060 9; t) Rexall, Manufactured For: Rexall Brads Corp., Mississauga, Ontario, L4Z 1R9., Imported by: Arrow OTC Company, Mississauga, Ontario L5N 2B8, UPC: 7 71058 10160 4; u) Rexall, Fabrique pour: Rexall Brands Corp., Mississauga, Ontario L4Z 1%9, Importe par: Arrow OTC Company, Mississauga, Ontario l5N 2B8, UPC: 7 71058 10160 4; v) select brand, Distributed by: SELECT BRAND DISTRIBUTORS, Pine Bluff, AR 71603, UPC: 0 15127 00066 6; w) Smart sense, Distributed by: Kmart Corgoration, Hoffman Estates, IL 60179, UPC: 7 20007 78036 0; x) sunmark, Cistributed By McKesson, One Post Street, San Francisco, CA 94104, UPC: 0 10939 16733 0, NDC: 49348-037-29; y) SWIFT, Distributed by Swift First Aid, Inc., Valencia, Calif. 91355; UPC: 6 69635 24061 0; z) TopCare, Distributed By Topco Associates LLC, 7711 Gross Point Road, Skokie, IL 60077, UPC: 0 36800 03639 0; aa) Western Family Foods, Distributed by: Western Family Foods, Inc., P.O. Box 4059, Portland, OR 97208, UPC:0 15400 03420 3;bb)  ZEE, Distributed by ZEE MEDICAL, INC., Irvine, CA 92606, UPC: 6 90689 00614 3.", "product_quantity": "751,440 Bottles", "reason_for_recall": "CGMP Deviations: Active Pharmaceutical Ingredient (API) used for manufacture was stored in a non-GMP compliant warehouse at S.I.M.S., Italy.", "recall_initiation_date": "20141204", "center_classification_date": "20141223", "termination_date": "20151026", "report_date": "20141231", "code_info": "Lot #: 3A001, Expiry: 01/16; Lot #: 3A002, Expiry: 01/16; Lot #: 3B004, Expiry: 02/16; Lot #: 3B003, Expiry: 02/16; Lot #: 3C005, Expiry: 03/16; Lot #: 3C006, Expiry: 03/16; Lot #: 3D007, Expiry: 04/16; Lot #: 3D008, Expiry: 04/16.", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88738", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0024-2022", "product_description": "AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd. by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-129-06.", "product_quantity": "4,850 inhalers", "reason_for_recall": "Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol", "recall_initiation_date": "20210922", "center_classification_date": "20211021", "termination_date": "20230216", "report_date": "20211027", "code_info": "AFR17A"}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89172", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "nationwide", "recall_number": "D-0440-2022", "product_description": "Profound Dental Gel, Lidocaine HCl/Prilocaine HCl/Tetracaine HCl, 10% / 10% / 4%, Spearmint-Peppermint, Multiple Dose Container for Topical Oral Use, Edge Pharma, LLC, 856 Hercules Dr. Colchester, VT  NDC 05446-0407-10", "product_quantity": "221 jars", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20211206", "center_classification_date": "20220124", "termination_date": "20230607", "report_date": "20220202", "code_info": "08-2021-16@12 02-01-2022 09/21/21 - 10/19/21 09-2021-13@8 02-01-2022 11/04/21 - 11/17/21 09-2021-29@8 03-01-2022 10/18/21 - 11/11/21 10-2021-26@7 04-24-2022 11/17/21 - 12/01/21", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-937-2013", "product_description": "ALPROSTADIL, 50 MCG/ML INJ SOLN, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "07232013@28", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0088-2017", "product_description": "remifentanil HCl, 50 mcg per mL, 100 mcg per 2 mL, in 0.9% Sodium Chloride, Preservative Free, 2 mL Total Volume in a syringe, Rx only, PharMEDium, Product code 2R3300.", "product_quantity": "1623 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot Numbers: 151680012C, 151720013C, 151730179M, 151740029M, 151790014C, 151880319M, 151890297M, 151890318M, 151900127M, 151930081M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93456", "recalling_firm": "SCA Pharmaceuticals, LLC", "address_1": "755 Rainbow Rd Ste B", "address_2": "N/A", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0400-2024", "product_description": "fentaNYL 500 mcg/100 mL, Bupivacaine HCl 0.04% in 0.9% Sodium Chloride 100 mL Injection (fentaNYL Concentration = 5 mcg/mL), EPIDURAL USE ONLY, 100 mL Yellow CADD Cassette, Rx only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT 06095, NDC 70004-0289-64, Bar Code 70004028964", "product_quantity": "412 cassettes", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20231109", "center_classification_date": "20240322", "termination_date": "20240827", "report_date": "20240403", "code_info": "Lot #: 1223049261, Exp 12/25/23; 1223049724, Exp 01/11/24", "more_code_info": ""}, {"status": "Terminated", "city": "Dallas", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72455", "recalling_firm": "Downing Labs, LLC", "address_1": "4001 McEwen Rd Suite 110", "address_2": "N/A", "postal_code": "75244-5020", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US; Australia, Brazil, Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, Phillippines, Singapore, Thailand, Trinidad and Tobago, Taiwan", "recall_number": "D-0355-2016", "product_description": "HCG (Lyophilized) Injectable, 5000 units/vial,  5mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435", "product_quantity": "1062 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20151016", "center_classification_date": "20151118", "termination_date": "20160922", "report_date": "20151125", "code_info": "All lots"}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71553", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave", "address_2": "Suite A", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-1225-2015", "product_description": "Famotidine tablets, USP 20mg, packaged in 10-count blisters (NDC 68084-172-11); 10 blister packs per carton (NDC 68084-172-01); Rx only,  Manufactured by: Wockhardt Limited, Mumbai, India, Distributed by: Wockhardt, USA, LLC 20 Waterview Blvd. Parsippany, NJ 07054 USA for American Health Packaging 2550-A John Glenn Avenue, Columbus, OH 43217.", "product_quantity": "97,837 cartons", "reason_for_recall": "CGMP Deviations: Firm did not adequately investigate customer complaints.", "recall_initiation_date": "20150601", "center_classification_date": "20150708", "termination_date": "20170222", "report_date": "20150715", "code_info": "Lot#: 132146, Exp 06/30/2015; Lot#: 132147, 132963,  Exp 08/31/2015; Lot#: 132964, Exp 10/31/2015; Lot#: 134319, Exp 12/31/2015; Lot#: 134320, Exp 01/31/2016."}, {"country": "United States", "city": "Vancouver", "address_1": "14301 Se 1st St", "reason_for_recall": "Labeling: Label Mixup; ASPIRIN EC DR Tablet, 81 mg may be potentially mislabeled as    MELATONIN, Tablet, 3 mg, NDC 51991001406, Pedigree: AD28322_7, EXP: 5/6/2014;  DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: W003671, EXP: 6/25/2014.", "address_2": "", "product_quantity": "544 Tablets", "code_info": "ASPIRIN EC DR, Tablet, 81 mg has the following codes    Pedigree: AD28349_1, EXP: 2/28/2014;  Pedigree: W003672, EXP: 2/28/2014.", "center_classification_date": "20140116", "distribution_pattern": "Repacked drugs were distributed in Arizona, California, Oregon, and Washington.", "state": "WA", "product_description": "ASPIRIN EC DR Tablet, 81 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 49348098015", "report_date": "20140122", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidapak Services, LLC", "recall_number": "D-585-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "65707", "termination_date": "20140207", "more_code_info": "", "recall_initiation_date": "20130702", "postal_code": "98684-3501", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "5 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine prostaglandin; 30/2 mg/25 mcg/mL;   5 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0708-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0875-2021", "product_description": "Althaea 30X, Iritable Bladder* Sucrose/Lactose Pills,  packaged as 4 Dram,  WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "10 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29377, Exp 8/17/2026"}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74187", "recalling_firm": "Well Care Compounding Pharmacy", "address_1": "3430 E Tropicana Ave Ste 9", "address_2": "N/A", "postal_code": "89121-7345", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "NV", "recall_number": "D-1002-2016", "product_description": "METHYLCOBALAMIN/FOLIC ACID; 10MG/0.8MG/ML, packaged in 1mL and 5mL vials, Rx only, Well Care Compounding Pharmacy Las Vegas, NV 89121", "product_quantity": "869 Units (Total All Products)", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection identified GMP violations potentially impacting product quality and sterility.", "recall_initiation_date": "20160517", "center_classification_date": "20160609", "termination_date": "20170113", "report_date": "20160615", "code_info": "Lot #: 01262016:86@2, Exp. 07/30/2016; 02222016:31@27, Exp. 08/20/2016; Lot #: 03022016:1@47, Exp. 08/29/2016; Lot #: 03032016:26@ 1, Exp. 08/30/2016; Lot #: 04122016: 84@227, Exp.10/15/2016."}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0612-2021", "product_description": "Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-3205-91", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BF84, Exp 06/30/2022"}, {"status": "Terminated", "city": "Palm Harbor", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81810", "recalling_firm": "Promise Pharmacy, LLC", "address_1": "31818 Us Highway 19 N", "address_2": "N/A", "postal_code": "34684-3713", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0435-2019", "product_description": "Prednisolone and Gatifloxacin and Bromfenac Ophthalmic Solution, 1%/0.5%/0.09%, Combo Drops 6 mL, Rx Only, Compounded Prescription, Promise Pharmacy 31818 US Hwy 19N, Palm Harbor FL 34684", "product_quantity": "2057 6 ml bottles", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20181217", "center_classification_date": "20190208", "termination_date": "20210330", "report_date": "20190220", "code_info": "Lots: 09192018@4 BUD: 12/18/2018; 10112018@1 BUD: 12/24/2018; 10262018@1 BUD: 1/8/2019; 10302018@1 BUD: 1/12/2019; 11082018@6 BUD: 1/21/2019"}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203817"], "brand_name": ["MESALAMINE"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2245"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["686429"], "spl_id": ["1300887a-c110-46b3-a8be-cfceabf0cbf2"], "spl_set_id": ["ba1e3bd4-fbe0-46a5-961e-167ccb09672c"], "package_ndc": ["0591-2245-22"], "is_original_packager": [true], "upc": ["0305912245229"], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "86667", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and PR", "recall_number": "D-0069-2021", "product_description": "Mesalamine Delayed-Release Tablets, USP 1.2 gram, 120 tablets per bottle, Rx Only, Manufactured by: Actavis Laboratories, FL, Inc., Fort Lauderdale, FL 33314, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054, NDC 0591-2245-22.", "product_quantity": "133,829 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out-of-specification dissolution results were obtained during stability testing.", "recall_initiation_date": "20201028", "center_classification_date": "20201106", "termination_date": "20210826", "report_date": "20201118", "code_info": "Lot #s: 1342498A, Exp. 12/2020; 1342499A, Exp. 01/2021; 1354638A, Exp. 03/2021; 1354639A, 1358274A, 1358448A, 1364618A, 1369884A, Exp. 05/2021; 1366195A, 1369885A, 1373570A, Exp. 06/2021; 1373571A, Exp. 07/2021; 1388571A, Exp. 01/2022; 1395725A, 1396585A, 1397550A, 1399389A, Exp. 04/2022; 1403885A, 1403886A, Exp. 06/2022.", "more_code_info": ""}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022088"], "brand_name": ["TORISEL"], "generic_name": ["TEMSIROLIMUS"], "manufacturer_name": ["Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc."], "product_ndc": ["0008-1179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["722289", "725108"], "spl_id": ["bf2e0d62-5f93-4a04-852b-829296b5bdd2"], "spl_set_id": ["95b7dc92-2180-42f1-8699-3c28f609e674"], "package_ndc": ["0008-1179-01", "0008-1279-01", "0008-1125-01"], "is_original_packager": [true]}, "product_type": "Drugs", "event_id": "64690", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-219-2013", "product_description": "TORISEL Kit (temsirolimus) injection, 25 mg/mL, CONCENTRATED, Rx Only,  Packaged in a carton containing 1 vial TORISEL injection and 1 vial DILUENT for TORISEL, Distributed by Wyeth Pharmaceuticals Inc., A subsidiary of Pfizer Inc., Philadelphia, PA --- NDC 0008-1179-01", "product_quantity": "10920 kits", "reason_for_recall": "Lack of Assurance of Sterility; potential that a low level of endotoxins may be present in the diluent vials.", "recall_initiation_date": "20121126", "center_classification_date": "20130326", "termination_date": "20150331", "report_date": "20130403", "code_info": "Lots P00025A; P00027B", "more_code_info": ""}, {"status": "Terminated", "city": "Tampa", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83996", "recalling_firm": "Coast Quality Pharmacy, LLC dba Anazao Health", "address_1": "5710 Hoover Blvd", "address_2": "N/A", "postal_code": "33634-5339", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0595-2020", "product_description": "Clonidine HCL in all strengths, all doses and all packaging, AnazaoHealth 5710 Hoover Blvd Tampa, FL 33634.", "product_quantity": "Unknown", "reason_for_recall": "Lack of Processing Controls; Environmental sampling revealed 1 CFU (Colony Forming Unit) identified as Talaromyces rotundus, a fungi.", "recall_initiation_date": "20190903", "center_classification_date": "20191206", "termination_date": "20201201", "report_date": "20191218", "code_info": "All lots filled and dispensed on 08/26-29/2019 and 09/27/2019 through 10/03/2019 remaining within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA201586"], "brand_name": ["TELMISARTAN AND AMLODIPINE"], "generic_name": ["TELMISARTAN AND AMLODIPINE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-196", "68180-197", "68180-198", "68180-199"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["AMLODIPINE BESYLATE", "TELMISARTAN"], "rxcui": ["876514", "876519", "876524", "876529"], "spl_id": ["17a6182b-5050-470e-aa1d-1605fa9e088e"], "spl_set_id": ["a97fefa6-99e6-4eb7-9393-ab2252a2c7d8"], "package_ndc": ["68180-196-06", "68180-196-09", "68180-196-12", "68180-197-06", "68180-197-09", "68180-197-12", "68180-197-07", "68180-198-06", "68180-198-09", "68180-198-12", "68180-199-06", "68180-199-09", "68180-199-12"], "is_original_packager": [true], "upc": ["0368180196068"], "nui": ["N0000000070", "N0000175561"], "pharm_class_moa": ["Angiotensin 2 Receptor Antagonists [MoA]"], "pharm_class_epc": ["Angiotensin 2 Receptor Blocker [EPC]"], "unii": ["864V2Q084H", "U5SYW473RQ"]}, "product_type": "Drugs", "event_id": "82528", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "111 S Calvert St Fl 21ST", "address_2": "N/A", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 6 wholesalers/ drug chains and 2 mail order pharmacies that may have further distribute the product throughout the United States.", "recall_number": "D-1121-2019", "product_description": "Telmisartan and Amlodipine Tablets 80 mg/5 mg, 30 tablet bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, MD, Manufactured by : Lupin Limited, Goa, INDIA -- NDC 68180-198-06", "product_quantity": "12,504 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; 18 month long term stability study.", "recall_initiation_date": "20190401", "center_classification_date": "20190411", "termination_date": "20200701", "report_date": "20190417", "code_info": "G705843 Exp. date April, 2019  G707763 Exp. date August, 2019  G800434 Exp. date November, 2019"}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "63384", "recalling_firm": "Raritan Pharmaceuticals, Inc.", "address_1": "8 Joanna Ct", "address_2": "N/A", "postal_code": "08816-2108", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-021-2013", "product_description": "Best Choice Health Care, Psyllium Fiber Supplement, 100% natural Psyllium Fiber Laxative, 100 capsules per bottle, Proudly Distributed by: Valu Merchandisers, Co., Kansas City, KS 06106, UPC 0-70038-63439-3", "product_quantity": "2160  bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products: Product is being recalled due to possible microbial contamination by C. difficile discovered in the raw material.", "recall_initiation_date": "20120904", "center_classification_date": "20121025", "termination_date": "20141007", "report_date": "20121031", "code_info": "Lot 16273, Exp 06/15"}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0791-2023", "product_description": "Cetrorelix Acetate for Injection, 0.25 mg, , One carton contains one packaged tray which contains: 1 vial with lyophilized powder for reconstitution, 1 pre-filled syringe with diluent, 1 20-gauge needle, 1 27-gauge needle, Sterile - For subcutaneous use only, Rx Only, Manufactured by: GP Pharm S.A. Barcelona, Spain (ESP) -08777, Distributed by: Akorn Operating Company, LLC., Gurnee, IL 60031.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"status": "Terminated", "city": "Seattle", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85706", "recalling_firm": "BIOTA Biosciences LLC", "address_1": "1601 5th Ave Ste 1100", "address_2": "N/A", "postal_code": "98101-3603", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States and New Zealand", "recall_number": "D-1326-2020", "product_description": "Sterile Cannabidiol (CBD) 4mg/mL, 10mL vial", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility and Marketed without an approved NDA/ANDA: Product contains unapproved Cannabidiol and Curcumin", "recall_initiation_date": "20200511", "center_classification_date": "20200619", "termination_date": "20201203", "report_date": "20200701", "code_info": "Lot #: 2H071219P, 2H0712019P,  2H07122019P, Exp. Date 7/12/2021"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "74057", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-1368-2016", "product_description": "0.25% Bupivacaine HCl (Preservative Free) in 0.9% Sodium Chloride; ,\tService Code\t2H8120\t,\tNDC\t61553-120-50\t,\t250 ml in 250 ml Hospira LifeCare Bag \t;  ,\tService Code\t2H8243\t,\tNDC\t61553-243-54\t,\t200 ml in 250 ml Hospira LifeCare Bag \t;  ,\tService Code\t2K8120\t,\tNDC\t61553-120-09\t,\t400 ml in 500 ml Baxter Intravia Bag \t;  ,\tService Code\t2K8243\t,\tNDC\t61553-243-37\t,\t200 ml in 250 ml Baxter Intravia Bag \t;  ,\tService Code\t2K9120\t,\tNDC\t61553-120-03\t,\t500 ml in 500 ml Baxter Intravia Bag \t;  ,\tService Code\t2N1120\t,\tNDC\t61553-120-84\t,\t400 ml in 500 ml Baxter Intravia Bag \t;  ,\tService Code\t2N9619\t,\tNDC\t61553-619-97\t,\t250 ml in 250 ml Baxter Intravia Bag   \t;  Rx Only, Compounded by PharMEDium Services, LLC, Memphis, TN 36141", "product_quantity": "2,874 bags", "reason_for_recall": "Presence of Particulate Matter: API contaminated with glass particulate was used to produce sterile injectable drugs.", "recall_initiation_date": "20160505", "center_classification_date": "20160716", "termination_date": "20180306", "report_date": "20160727", "code_info": "Service Code 2H8120 , Lot Number 160380137M , Exp. Date 5/8/2016 ;  Service Code 2H8120 , Lot Number 160420181M , Exp. Date 5/12/2016 ;  Service Code 2H8120 , Lot Number 160450166M , Exp. Date 5/15/2016 ;  Service Code 2H8120 , Lot Number 160460209M , Exp. Date 5/16/2016 ;  Service Code 2H8120 , Lot Number 160600277M , Exp. Date 5/30/2016 ;  Service Code 2H8120 , Lot Number 160610057M , Exp. Date 5/30/2016 ;  Service Code 2H8120 , Lot Number 160610224M , Exp. Date 5/31/2016 ;  Service Code 2H8120 , Lot Number 160680153M , Exp. Date 6/7/2016 ;  Service Code 2H8120 , Lot Number 160810219M , Exp. Date 6/20/2016 ;  Service Code 2H8120 , Lot Number 160910124M , Exp. Date 6/29/2016 ;  Service Code 2H8120 , Lot Number 160960220M , Exp. Date 7/5/2016 ;  Service Code 2H8243 , Lot Number 160530200M , Exp. Date 5/9/2016 ;  Service Code 2H8243 , Lot Number 160600047M , Exp. Date 5/16/2016 ;  Service Code 2H8243 , Lot Number 160670033M , Exp. Date 5/22/2016 ;  Service Code 2H8243 , Lot Number 160810051M , Exp. Date 6/5/2016 ;  Service Code 2H8243 , Lot Number 160880267M , Exp. Date 6/13/2016 ;  Service Code 2H8243 , Lot Number 160910035M , Exp. Date 6/15/2016 ;  Service Code 2H8243 , Lot Number 160950059M , Exp. Date 6/19/2016 ;  Service Code 2K8120 , Lot Number 160480190M , Exp. Date 5/18/2016 ;  Service Code 2K8120 , Lot Number 160550194M , Exp. Date 5/25/2016 ;  Service Code 2K8120 , Lot Number 160940060M , Exp. Date 7/2/2016 ;  Service Code 2K8243 , Lot Number 160410183M , Exp. Date 5/11/2016 ;  Service Code 2K8243 , Lot Number 160420152M , Exp. Date 5/12/2016 ;  Service Code 2K8243 , Lot Number 160460131M , Exp. Date 5/16/2016 ;  Service Code 2K8243 , Lot Number 160490239M , Exp. Date 5/19/2016 ;  Service Code 2K8243 , Lot Number 160520184M , Exp. Date 5/22/2016 ;  Service Code 2K8243 , Lot Number 160550125M , Exp. Date 5/25/2016 ;  Service Code 2K8243 , Lot Number 160590160M , Exp. Date 5/29/2016 ;  Service Code 2K8243 , Lot Number 160600171M , Exp. Date 5/30/2016 ;  Service Code 2K8243 , Lot Number 160610227M , Exp. Date 5/31/2016 ;  Service Code 2K8243 , Lot Number 160620142M , Exp. Date 6/1/2016 ;  Service Code 2K8243 , Lot Number 160630199M , Exp. Date 6/2/2016 ;  Service Code 2K8243 , Lot Number 160660168M , Exp. Date 6/5/2016 ;  Service Code 2K8243 , Lot Number 160670236M , Exp. Date 6/6/2016 ;  Service Code 2K8243 , Lot Number 160700192M , Exp. Date 6/9/2016 ;  Service Code 2K8243 , Lot Number 160740235M , Exp. Date 6/13/2016 ;  Service Code 2K8243 , Lot Number 160760190M , Exp. Date 6/15/2016 ;  Service Code 2K8243 , Lot Number 160810280M , Exp. Date 6/20/2016 ;  Service Code 2K8243 , Lot Number 160820234M , Exp. Date 6/21/2016 ;  Service Code 2K8243 , Lot Number 160830120M , Exp. Date 6/21/2016 ;  Service Code 2K8243 , Lot Number 160870168M , Exp. Date 6/26/2016 ;  Service Code 2K8243 , Lot Number 160900173M , Exp. Date 6/29/2016 ;  Service Code 2K8243 , Lot Number 160910176M , Exp. Date 6/30/2016 ;  Service Code 2K8243 , Lot Number 160940041M , Exp. Date 7/2/2016 ;  Service Code 2K8243 , Lot Number 161080168M , Exp. Date 7/17/2016 ;  Service Code 2K9120 , Lot Number 160380034C , Exp. Date 5/8/2016 ;  Service Code 2K9120 , Lot Number 160380105M , Exp. Date 5/8/2016 ;  Service Code 2K9120 , Lot Number 160420030C , Exp. Date 5/12/2016 ;  Service Code 2K9120 , Lot Number 160470039C , Exp. Date 5/17/2016 ;  Service Code 2K9120 , Lot Number 160540034C , Exp. Date 5/24/2016 ;  Service Code 2K9120 , Lot Number 160550029C , Exp. Date 5/25/2016 ;  Service Code 2K9120 , Lot Number 160590078M , Exp. Date 5/29/2016 ;  Service Code 2K9120 , Lot Number 160600067M , Exp. Date 5/29/2016 ;  Service Code 2K9120 , Lot Number 160670187M , Exp. Date 6/6/2016 ;  Service Code 2K9120 , Lot Number 160730076M , Exp. Date 6/11/2016 ;  Service Code 2K9120 , Lot Number 160750233M , Exp. Date 6/14/2016 ;  Service Code 2K9120 , Lot Number 160770001M , Exp. Date 6/15/2016 ;  Service Code 2K9120 , Lot Number 160770049M , Exp. Date 6/15/2016 ;  Service Code 2K9120 , Lot Number 160810056M , Exp. Date 6/19/2016 ;  Service Code 2K9120 , Lot Number 160870069M , Exp. Date 6/26/2016 ;  Service Code 2K9120 , Lot Number 160910184M , Exp. Date 6/30/2016 ;  Service Code 2K9120 , Lot Number 160940154M , Exp. Date 7/3/2016 ;  Service Code 2K9120 , Lot Number 160960190M , Exp. Date 7/5/2016 ;  Service Code 2K9120 , Lot Number 161080156M , Exp. Date 7/17/2016 ;  Service Code 2N1120 , Lot Number 160960241M , Exp. Date 7/5/2016 ;  Service Code 2N9619 , Lot Number 160950229M , Exp. Date 7/4/2016 ;  Service Code 2R3317-5 , Lot Number 160420122M , Exp. Date 5/12/2016 ;  Service Code 2R3317-5 , Lot Number 160550206M , Exp. Date 5/24/2016 ;  Service Code 2R3317-5 , Lot Number 160590164M , Exp. Date 5/29/2016 ;  Service Code 2R3317-5 , Lot Number 160660159M , Exp. Date 6/5/2016 ;  Service Code 2R3317-5 , Lot Number 160690151M , Exp. Date 6/7/2016 ;  Service Code 2R3317-5 , Lot Number 160740252M , Exp. Date 6/13/2016 ;  Service Code 2R3317-5 , Lot Number 160750181M , Exp. Date 6/14/2016 ;  Service Code 2R3317-5 , Lot Number 160810298M , Exp. Date 6/20/2016 ;  Service Code 2R3317-5 , Lot Number 160830222M , Exp. Date 6/22/2016 ;  Service Code 2R3317-5 , Lot Number 160940150M , Exp. Date 7/3/2016 ;  Service Code 2R3317-5 , Lot Number 161080209M , Exp. Date 7/17/2016 ;  Service Code 3317NO , Lot Number 160380157M , Exp. Date 5/8/2016 ;  Service Code 3317NO , Lot Number 160420173M , Exp. Date 5/11/2016 ;  Service Code 3317NO , Lot Number 160540140M , Exp. Date 5/24/2016 ;  Service Code 3317NO , Lot Number 160600185M , Exp. Date 5/30/2016 ;  Service Code 3317NO , Lot Number 160630204M , Exp. Date 6/2/2016 ;  Service Code 3317NO , Lot Number 160660172M , Exp. Date 6/5/2016 ;  Service Code 3317NO , Lot Number 160700219M , Exp. Date 6/9/2016 ;  Service Code 3317NO , Lot Number 160770174M , Exp. Date 6/16/2016 ;  Service Code 3317NO , Lot Number 160840205M , Exp. Date 6/23/2016 ;  Service Code 3317NO , Lot Number 160910210M , Exp. Date 6/30/2016 ;  Service Code 3317NO , Lot Number 161080215M , Exp. Date 7/17/2016 ;", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0174-2024", "product_description": "Colgate Total SF Toothpaste, Net Wt 4.8 oz (136 g), Stannous Fluoride 0.454%, Clean Mint, Dist. by: COLGATE-PALMOLIVE CO., New York, NY 10022 USA", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 1293US561C", "more_code_info": ""}, {"status": "Terminated", "city": "Bellflower", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72361", "recalling_firm": "Pacific Healthcare, Inc dba B&B Pharmacy", "address_1": "10244 Rosecrans Ave", "address_2": "N/A", "postal_code": "90706-2602", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and NJ", "recall_number": "D-0167-2016", "product_description": "Testosterone Cypionate 250 mg/mL Injection, 10 mL vial, Rx, B & B Health Mart Pharmacy, Bellflower, CA", "product_quantity": "3 vials", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "recall_initiation_date": "20151007", "center_classification_date": "20151110", "termination_date": "20160407", "report_date": "20151118", "code_info": "07282015@7, exp 10/26/2015, 07292015@6, 10/27/2015, 08252015@4, 11/23/2015"}, {"status": "Terminated", "city": "Moses Lake", "state": "WA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71806", "recalling_firm": "JD & SN Inc., dba Moses Lake Professional Pharmacy", "address_1": "1555 Pilgrim St", "address_2": "N/A", "postal_code": "98837-4623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0117-2016", "product_description": "PROGESTERONE, Pellet, 200 mg, Rx only, JD & SN Inc, DBA Moses Lake Professional Pharmacy, 1555 S. Pilgrim St. Moses Lake WA  98837, (509)764-2314", "product_quantity": "5 pellets", "reason_for_recall": "Lack of Assurance of Sterility; all sterile human compounded drugs within expiry", "recall_initiation_date": "20150724", "center_classification_date": "20151027", "termination_date": "20160413", "report_date": "20151104", "code_info": "t08042014@18, t07082015@26, t07072015@12, t03132015@6, t02162015@12."}, {"status": "Terminated", "city": "Eatontown", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA091032"], "brand_name": ["IRINOTECAN HYDROCHLORIDE"], "generic_name": ["IRINOTECAN HYDROCHLORIDE"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0143-9701", "0143-9702"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["IRINOTECAN HYDROCHLORIDE"], "rxcui": ["1726319", "1726324"], "spl_id": ["204eb37a-642f-4321-9466-414c32a6bbce"], "spl_set_id": ["be716692-6b4f-47b6-83d1-01665861626b"], "package_ndc": ["0143-9702-01", "0143-9701-01"], "is_original_packager": [true], "upc": ["0301439701019"], "unii": ["042LAQ1IIS"]}, "product_type": "Drugs", "event_id": "66447", "recalling_firm": "West-Ward Pharmaceutical Corp.", "address_1": "465 Industrial Way W", "address_2": "N/A", "postal_code": "07724-2209", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-66447-001", "product_description": "Irinotecan Hydrochloride Injection, 40 mg/2 mL (20 mg/mL), 1 x 2 mL Single Dose Vial per carton, Rx only, Manufactured by: Thymoorgan Pharmazie GmbH, Schiffgraben 23, 38690 Vienenburg, Germany; Distributed by: West-Ward Pharmaceutical Corp., Eatontown, NJ  07724 USA, NDC 0143-9702-01.", "product_quantity": "9020 vials", "reason_for_recall": "Superpotent Drug: a recent review of the USP revealed that an incorrect calculation was used to determine the amount of irinotecan to use in formulation which will result in an assay higher than the labeled claim.", "recall_initiation_date": "20130923", "center_classification_date": "20131104", "termination_date": "20160405", "report_date": "20131113", "code_info": "Lot #: AC0020, Exp 03/14; AC0023, AC0025, Exp 08/14"}, {"status": "Ongoing", "city": "North Wales", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "80538", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "1090 Horsham Rd", "address_2": "N/A", "postal_code": "19454-1505", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Product was distributed throughout the United States, including Hawaii and Puerto Rico", "recall_number": "D-0986-2018", "product_description": "Valsartan Tablets, USP 40 mg, 30-count bottle (NDC 0591-2167-30), 90-count bottle (NDC 0591-2167-19), Rx Only, Rx Only, Manufactured by: Arrow Pharma (Malta) Ltd. India, Distributed by: Actavis Pharma, Inc. Parsippany, NJ 07054", "product_quantity": "8,046 30-count bottles, 20,841 90-count bottles", "reason_for_recall": "CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.", "recall_initiation_date": "20180716", "center_classification_date": "20180724", "report_date": "20180801", "code_info": "Lot Numbers:  NDC 0591-2167-30  1196936A, 1238463A, 1270617A  NDC 0591-2167-19   1196934M, 1238462M, 1268429A"}, {"status": "Terminated", "city": "Latham", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70807", "recalling_firm": "Fallon Wellness Pharmacy, L.L.C.", "address_1": "1057 Troy Schenectady Rd", "address_2": "N/A", "postal_code": "12110-1002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "New York", "recall_number": "D-1073-2015", "product_description": "Papaverine/phentolamine/prostaglandin 30/1/0.01mg/mL Injection, Fallon Wellness Pharmacy, L.L.C., Latham, NY 12110", "product_quantity": "8 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20150317", "center_classification_date": "20150512", "termination_date": "20180605", "report_date": "20150520", "code_info": "Lot#: 12302014@9; Exp 4/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Southfield", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65876", "recalling_firm": "Beacon Hill Medical Pharmacy, P.C.", "address_1": "18161 W 13 Mile Rd", "address_2": "Suite A1", "postal_code": "48076-1113", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "USA nationwide", "recall_number": "D-959-2013", "product_description": "FUROSEMIDE 10 MG/ML INJECTABLE, all presentations, FOR INTRAVENO AND SQ USE ONLY, STERILE, RX ONLY, Compounded by Beacon Hill Medical Pharmacy PC, dba Rxtra Solutions, Southfield, MI", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance", "recall_initiation_date": "20130726", "center_classification_date": "20130910", "termination_date": "20140718", "report_date": "20130918", "code_info": "01162013@14, 02132013@18", "more_code_info": ""}, {"status": "Terminated", "city": "Port Charlotte", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "85404", "recalling_firm": "The Medicine Shoppe Pharmacy", "address_1": "3524b Tamiami Trl", "address_2": "", "postal_code": "33952-8100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Florida", "recall_number": "D-1195-2020", "product_description": "Ergotamine Tartrate 1 mg/Caffeine 100 mg Base Suppository (Pink) 48 count box, Rx, The Medicine Shoppe Pharmacy, Port Charlotte, FL", "product_quantity": "1 box", "reason_for_recall": "Lack of Processing Control", "recall_initiation_date": "20200406", "center_classification_date": "20200410", "termination_date": "20221213", "report_date": "20200422", "code_info": "Lot: 45247 Discard by: 9/19/2020", "more_code_info": ""}, {"status": "Completed", "city": "Aquebogue", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83265", "recalling_firm": "Altaire Pharmaceuticals, Inc.", "address_1": "311 W Ln", "address_2": "PO Box 849", "postal_code": "11931-0849", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "U.S.A. Nationwide", "recall_number": "D-0450-2020", "product_description": "OCuSOFT Tears Again Lubricant Eye Drops, Net Wt. 15 mL (0.5 fl oz), Manufactured for OCuSOFT Inc. Rosenberg, TX 77471 USA, NDC 54799-904-15", "product_quantity": "81217 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20190702", "center_classification_date": "20191115", "report_date": "20191127", "code_info": "17209  7/21    18168  7/22    18217  8/22    18260  10/22    19094  4/23"}, {"status": "Terminated", "city": "WILMINGTON", "state": "DE", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA022101"], "brand_name": ["NEXIUM"], "generic_name": ["ESOMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["AstraZeneca Pharmaceuticals LP"], "product_ndc": ["0186-4010", "0186-5020", "0186-4020", "0186-4040", "0186-5040", "0186-4025", "0186-4050"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESOMEPRAZOLE MAGNESIUM"], "rxcui": ["606726", "606728", "606730", "606731", "692576", "692578", "861568", "861570", "861576", "861583", "1297658", "1297660", "1297761", "1297763"], "spl_id": ["e84bdda0-3dbf-4166-9ce2-13ee23629029"], "spl_set_id": ["f4853677-1622-4037-688b-fdf533a11d96"], "package_ndc": ["0186-5020-31", "0186-5020-54", "0186-5020-82", "0186-4010-01", "0186-4010-02", "0186-4020-01", "0186-4040-01", "0186-4040-02", "0186-5040-31", "0186-5040-35", "0186-5040-55", "0186-5040-85", "0186-5040-54", "0186-5040-82", "0186-5040-05", "0186-4025-01", "0186-4025-02", "0186-4050-01"], "is_original_packager": [true], "unii": ["R6DXU4WAY9"], "upc": ["301865040850"]}, "product_type": "Drugs", "event_id": "62439", "recalling_firm": "ASTRA ZENECA Lp", "address_1": "1800 CONCORD PIKE", "address_2": "", "postal_code": "19803-2902", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-1410-2012", "product_description": "Nexium (esomeprazole magnesium) Delayed-Release Capsules, 40 mg, 1000-count bottle, Rx only, Manufactured for: AstraZeneca LP, Wilmington, DE  19850; By: AstraZeneca AB, S-151 85 Sodertalje, Sweden, NDC 0186-5040-85, UPC 3 0186-5040-85 0.", "product_quantity": "2,556 bottles", "reason_for_recall": "Adulterated Presence of Foreign Tablets/Capsules: Some bottles may contain a small number of Nexium 20 mg capsules intended for the Japanese market in addtion to Nexium 40 mg capsules.", "recall_initiation_date": "20120702", "center_classification_date": "20120711", "termination_date": "20130411", "report_date": "20120718", "code_info": "Lot #: H008328, Exp 11/14", "more_code_info": ""}, {"status": "Completed", "city": "New Albany", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA212593"], "brand_name": ["VASOPRESSIN"], "generic_name": ["VASOPRESSIN"], "manufacturer_name": ["American Regent, Inc."], "product_ndc": ["0517-1020", "0517-1030"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VASOPRESSIN"], "rxcui": ["313578", "2103182"], "spl_id": ["36148e09-1c3c-4878-a194-8e10291972ff"], "spl_set_id": ["0ab267f4-9ec9-44fd-8521-f975074667d9"], "package_ndc": ["0517-1020-01", "0517-1020-25", "0517-1030-01"], "is_original_packager": [true], "upc": ["0305171030017"], "nui": ["M0022562", "N0000009908", "N0000175360"], "pharm_class_cs": ["Vasopressins [CS]"], "pharm_class_pe": ["Vasoconstriction [PE]", "Decreased Diuresis [PE]"], "unii": ["Y4907O6MFD"]}, "product_type": "Drugs", "event_id": "94619", "recalling_firm": "American Regent, Inc.", "address_1": "6610 New Albany Rd E", "address_2": "", "postal_code": "43054-8730", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0507-2024", "product_description": "Vasopressin Injection, USP, 200 Units per 10 mL (20 Units per mL), 10 mL Multiple-Dose Vial, Rx only,  For Intravenous Infusion, American Regent, Inc., Shirley, NY 11967, NDC 0517-1030-01", "product_quantity": "2,352 vials", "reason_for_recall": "Subpotent product in addition to having out-of-specification results for impurities.", "recall_initiation_date": "20240513", "center_classification_date": "20240521", "report_date": "20240529", "code_info": "Lot #: 23061L1C0, Exp 1/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81002", "recalling_firm": "Pharm D Solutions, LLC", "address_1": "1304 S Loop W", "address_2": "N/A", "postal_code": "77054-4010", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0165-2019", "product_description": "Levocarnitine 170 mg/mL Injectable, Pharm D Solutions, Houston, Texas --- NDC 69699-1617-10", "product_quantity": "3000 milliliters", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20180910", "center_classification_date": "20181101", "termination_date": "20210205", "report_date": "20181107", "code_info": "Lot: 04232018:63 Discard by: 10/20/2018"}, {"status": "Terminated", "city": "Aurora", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71535", "recalling_firm": "the Compounder", "address_1": "340 Marshall Ave Unit 100", "address_2": "N/A", "postal_code": "60506-5649", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "Nationwide", "recall_number": "D-0221-2016", "product_description": "ESTRIOL (E3) 2.5MG suppositories, Rx only, The Compounder, 340 Marshall Avenue Unit 100, Aurora, IL 60506.", "product_quantity": "20 suppositories", "reason_for_recall": "Recalled products were made using an active ingredient that was recalled by a supplier due to penicillin cross contamination.", "recall_initiation_date": "20150310", "center_classification_date": "20151110", "termination_date": "20160519", "report_date": "20151118", "code_info": "Lot # 01132015:97@2, Exp 4/13/2015"}, {"status": "Terminated", "city": "Houston", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "84546", "recalling_firm": "Assurance Infusion", "address_1": "2626 S Loop W Ste 555", "address_2": "", "postal_code": "77054-2652", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0722-2020", "product_description": "CLON 300MCG/MORP 10MG/ML  INJ in 20 mL syringe  Assurance Infusion (713) 533-8800", "product_quantity": "1 syringe", "reason_for_recall": "Lack of sterility assurance.", "recall_initiation_date": "20191220", "center_classification_date": "20200113", "termination_date": "20211027", "report_date": "20200122", "code_info": "Lot: 12132019@8 Exp. 12/22/2019", "more_code_info": ""}, {"status": "Ongoing", "city": "Gurnee", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91788", "recalling_firm": "Akorn, Inc.", "address_1": "5605 Centerpoint Ct Ste A", "address_2": "N/A", "postal_code": "60031-5278", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0809-2023", "product_description": "HydrALAZINE HCl Injection, USP, 20 mg/mL, 1 mL Single Dose vials, For Intramuscular or Intravenous Use, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045.  ALL NDCs", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Firm went out of business and could no longer continue stability studies.", "recall_initiation_date": "20230426", "center_classification_date": "20230601", "report_date": "20230607", "code_info": "All Lots"}, {"country": "United States", "city": "Lincoln", "address_1": "10401 Hwy 6", "reason_for_recall": "Presence of Foreign Substance: The products are being recalled because they may contain foreign substances.", "address_2": "", "product_quantity": "", "code_info": "Lot #: 10122293, Exp 8/31/2013.", "center_classification_date": "20140117", "distribution_pattern": "Nationwide, Mexico, Russia, Korea, Panama, China, and Canada.", "state": "NE", "product_description": "NeoCitran DM Cough & Cold (dextromethorphan hydrobromide 30 mg, phenylephrine hydrochloride 10 mg, pheniramine maleate 20 mg) powder packets, Natural Source Lemon flavor, 10-count single dose pouches per carton, Novartis Consumer Health Canada, Inc., Mississauga, ON, UPC 0 58478 05503 9.", "report_date": "20140129", "classification": "Class II", "openfda": {}, "recalling_firm": "Novartis Consumer Health", "recall_number": "D-760-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "65490", "termination_date": "20141104", "more_code_info": "", "recall_initiation_date": "20130618", "postal_code": "68517-9626", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022417"], "brand_name": ["NORVIR"], "generic_name": ["RITONAVIR"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-2340", "0074-3333", "0074-1940", "0074-3399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RITONAVIR"], "rxcui": ["152971", "199249", "900575", "900577", "1926066", "1926069"], "spl_id": ["8ac33865-3c6e-4159-9eaf-5f62bee5b6ca"], "spl_set_id": ["2849298e-de6e-47bb-8194-56e075b33fc3"], "package_ndc": ["0074-3333-30", "0074-1940-63", "0074-3399-30", "0074-2340-30"], "is_original_packager": [true], "upc": ["0300742340304"], "nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "unii": ["O3J8G9O825"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0404-2021", "product_description": "Norvir Ritonavir Tablets 100 mg 30 Tablets Rx only NDC 0074-3333-30 Abbott Laboratories North Chicago, IL 60064, U.S.A.", "product_quantity": "362 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1131141"}, {"status": "Terminated", "city": "Tarrytown", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83417", "recalling_firm": "Medtech Products, Inc.", "address_1": "660 White Plains Rd Ste 250", "address_2": "N/A", "postal_code": "10591-5171", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico, St. Michael, Barbados, Guyana, St. Johns, Antigua and Barbuda, Kingston 5, and Jamaica.", "recall_number": "D-1833-2019", "product_description": "Clear Eyes Redness Relief Handy Pocket Pal Club Pak Display; each display (case UPC 30300742541283) contains 48 each of Clear eyes REDNESS RELIEF (Glycerin 0.25%, Naphazoline hydrochloride 0.012%) eye drops, 0.2 FL OZ (6 mL) bottle, Handy Pocket Pal (UPC 6 78112 25418 7); Distributed by Medtech Products Inc., Tarrytown, NY  10591; A Prestige Brands Company.", "product_quantity": "793,872 bottles", "reason_for_recall": "CGMP Deviations: concerns regarding the sufficiency of Quality Assurance controls over critical systems in the manufacturing facility that could impact the product quality of the finished products.", "recall_initiation_date": "20190726", "center_classification_date": "20190816", "termination_date": "20210310", "report_date": "20190828", "code_info": "Lot # 16242, Exp 09/19; 16280, Exp 10/19; 17051, Exp 02/20; 17130, Exp 04/20"}, {"status": "Terminated", "city": "Manassas", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87627", "recalling_firm": "Antoto-K", "address_1": "7686 Chadds Landing Way", "address_2": "N/A", "postal_code": "20111-1772", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0366-2021", "product_description": "Thumbs Up 7 Red 70K, 10 count blister pack cartons, Distributed by Ummzy LLC., Made in USA, UPC 6 17135 89467 3.", "product_quantity": "200 cartons", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.", "recall_initiation_date": "20210326", "center_classification_date": "20210504", "termination_date": "20220418", "report_date": "20210512", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-607-2015", "product_description": "Cyclosporine A active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "42756 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Monterey Park", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "83437", "recalling_firm": "Herbal Doctor Remedies", "address_1": "497 Cumbre St", "address_2": "N/A", "postal_code": "91754-2114", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "Nationwide within the United States and Brazil and on the internet", "recall_number": "D-1607-2019", "product_description": "Lung Fixer Capsules, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.", "recall_initiation_date": "20190712", "center_classification_date": "20190802", "termination_date": "20230613", "report_date": "20190814", "code_info": "All lots within expiry"}, {"status": "Completed", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "90204", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in th USA, Puerto Rico and US Virgin Islands", "recall_number": "D-0933-2022", "product_description": "Lipostat-Plus Methionine 25 mg/mL Inositol 50 mg/mL Choline Chloride 50 mg/mL Cyanocobalamin 1 mg/mL Pyridoxine HCL 175 mcg/mL, Multi-Dose 30 mL vial, Rx Only, Olympia Pharmaceuticals,  6700 Conroy Rd., Ste. 155 Orlando, FL 32835. NDC 73198-0047-30.", "product_quantity": "4843 vials", "reason_for_recall": "Lack of assurance of sterility.", "recall_initiation_date": "20220509", "center_classification_date": "20220525", "report_date": "20220601", "code_info": "Lots: A24H26-22, A24G26-22 BUD: 7/26/2022, K24130 BUD: 5/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "71328", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "United States Nationwide", "recall_number": "D-1116-2015", "product_description": "Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only. Manufactured for: Teva Pharmaceuticals USA Sailorsville, PA 13960. Manufactured in Canada By: Valeant Pharmaceuticals International, Inc. Steinbach, MB R5G 127 Canada. NDC: 0093-2059-01.", "product_quantity": "93,237 Bottles", "reason_for_recall": "Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time point.", "recall_initiation_date": "20150417", "center_classification_date": "20150608", "termination_date": "20160412", "report_date": "20150617", "code_info": "Lot #: 1309T27; Expiry: 8/15; Lot #: 1309T28, Expiry: 8/15; Lot #: 1311T33, Expiry: 10/15; Lot #: 1311T34, Expiry: 10/15, Lot #:  1312T40, Expiry: 11/15; Lot #: 1312T41, Expiry: 11/15; Lot #: 1403T23, Expiry: 02/16; Lot #: 1403T21, Expiry: 02/16; Lot #: 1405T21, Expiry: 04/16; Lot #:1405T22, Expiry: 04/16."}, {"country": "United States", "city": "Berkeley", "address_1": "2320 Woolsey St", "reason_for_recall": "Lack of Assurance of Sterility: Firm is recalling all unexpired lots of sterile compounded products after FDA inspection found concerns of lack of sterility assurance.", "address_2": "", "product_quantity": "30 ml", "code_info": "All lots", "center_classification_date": "20160217", "distribution_pattern": "CA", "state": "CA", "product_description": "papaverine phentolamine 30 mg/1mg/mL, 5 mL and 10 mL unit size, refrigerate, This Rx is Compounded, Abbott's Compounding Pharmacy, Berkeley, CA 94705", "report_date": "20160224", "classification": "Class II", "openfda": {}, "recalling_firm": "Abbott's Compounding Pharmacy, Inc.", "recall_number": "D-0690-2016", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "73090", "termination_date": "20170406", "more_code_info": "", "recall_initiation_date": "20160115", "postal_code": "94705-1973", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Sterling", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91443", "recalling_firm": "Northern VA Compounders PLLC", "address_1": "23475 Rock Haven Way", "address_2": "Suite 105", "postal_code": "20166-4444", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0111-2023", "product_description": "Prostaglandin (E1) Injection Solution, 25mcg/ml, 2.5 mL Multiple-Dose vials, Rx Only, Compounded by: Akina Pharmacy, 23475 Rock Haven Way Suite 105, Sterling, VA  20166.", "product_quantity": "108 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20221230", "center_classification_date": "20230112", "termination_date": "20230621", "report_date": "20230118", "code_info": "Lot#: 11252022@12, Exp 1/9/2023", "more_code_info": ""}, {"status": "Terminated", "city": "North Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "71973", "recalling_firm": "Ohm Laboratories, Inc.", "address_1": "1385 Livingston Ave", "address_2": "N/A", "postal_code": "08902-1829", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0022-2016", "product_description": "CareOne Original Prescription Strength, Allergy Relief, Loratadine Orally Disintegrating Tablets, USP, 10 mg, packaged in a) 10-count tablets per box, NDC 41520-525-69, UPC 3 41520 31346 2; b) Children's 10-count tablets per box NDC 41520-527-69, UPC 3 41520 31455 1; Distributed by: American Sales Company, 4201 Walden Avenue, Lancaster, NY  14086", "product_quantity": "21,356 boxes", "reason_for_recall": "Superpotent Drug: Out Of Specification (OOS) result for Assay.", "recall_initiation_date": "20150728", "center_classification_date": "20151015", "termination_date": "20161028", "report_date": "20151021", "code_info": "Batch Numbers:  (a) 2617891, Exp 5/31/2016; 2600127, Exp 2/29/2016; 2544487, Exp 7/31/2015;   2610783, Exp 4/30/2016  (b) 2600127, Exp 2/29/2016; 2544487, Exp 7/31/2015; 2617891, Exp 5/31/2016; 2644272, Exp 9/30/2016"}, {"status": "Terminated", "city": "Zebulon", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA204790"], "brand_name": ["TIVICAY"], "generic_name": ["DOLUTEGRAVIR SODIUM"], "manufacturer_name": ["ViiV Healthcare Company"], "product_ndc": ["49702-226", "49702-255", "49702-227", "49702-228"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOLUTEGRAVIR SODIUM"], "rxcui": ["1433873", "1433879", "1796077", "1796079", "1796081", "1796083", "2374562", "2374566"], "spl_id": ["a9175b83-2200-4bd2-9ee3-52095b5d2657"], "spl_set_id": ["63df5af3-b8ac-4e76-9830-2dbb340af922"], "package_ndc": ["49702-255-37", "49702-226-13", "49702-227-13", "49702-228-13"], "is_original_packager": [true], "upc": ["0349702227132", "0349702226135", "0349702228139"], "unii": ["1Q1V9V5WYQ"]}, "product_type": "Drugs", "event_id": "90166", "recalling_firm": "GlaxoSmithKline LLC", "address_1": "1011 N Arendell Ave", "address_2": "", "postal_code": "27597-2309", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0896-2022", "product_description": "Tivicay (dolutegravir) Tablets 50 mg, 30-count Bottle, Rx Only, Manufactured for: ViiV Healthcare RTP, NC 27709, NDC 49702-228-13.", "product_quantity": "328 bottles", "reason_for_recall": "Labeling: incorrect or missing lot and/or expiration date. An incorrect expiration date was printed on the product labeling with an expiration date of January 2027, whereas the correct expiration date is September 2026.", "recall_initiation_date": "20220513", "center_classification_date": "20220525", "termination_date": "20230817", "report_date": "20220601", "code_info": "Lot: 2A9E, Exp 1/2027", "more_code_info": ""}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "73925", "recalling_firm": "Pharmedium Services, LLC", "address_1": "150 N Field Dr Ste 350", "address_2": "N/A", "postal_code": "60045-2506", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0063-2017", "product_description": "lidocaine HCl, 1%, in 0.9% Sodium Chloride, Preservative Free, Total Volume 1 mL in a syringe, Rx only, PharMEDium, Product code 2R3345.", "product_quantity": "5900 syringes", "reason_for_recall": "Stability Data Does Not Support Expiry: potential loss of potency in drugs packaged and stored in syringes.", "recall_initiation_date": "20150717", "center_classification_date": "20161012", "termination_date": "20170623", "report_date": "20161019", "code_info": "Lot numbers: 15118046M, 15128003M, 15128111M, 15133006M, 15139004M, 15140015C, 15146086M, 15150029M, 15153004M, 151660012C, 151720052C, 151730131C, 151740007C, 151750019C, 151760011C, 151800048C,151880154M, Exp between 07/15/15-10/12/15"}, {"status": "Terminated", "city": "Toronto", "state": "", "country": "Canada", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "70452", "recalling_firm": "Attix Pharmaceuticals", "address_1": "184 Front St E", "address_2": "unit 801", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide to compounding pharmacies and research organizations.", "recall_number": "D-584-2015", "product_description": "Cidofovir Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada", "product_quantity": "540.75 grams", "reason_for_recall": "Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.", "recall_initiation_date": "20141114", "center_classification_date": "20150420", "termination_date": "20151007", "report_date": "20150429", "code_info": "All lots repackaged and distributed between 01/05/12 to 02/12/15", "more_code_info": ""}, {"country": "United States", "city": "Horsham", "address_1": "425 Privet Rd", "reason_for_recall": "CGMP Deviations; laboratory testing was not followed in accordance with GMP requirements", "address_2": "", "product_quantity": "2532 bottles", "code_info": "TE36018,  Exp. 06/15", "center_classification_date": "20140512", "distribution_pattern": "Nationwide", "state": "PA", "product_description": "GLYBURIDE and METFORMIN HYDROCHLORIDE Tablets USP, 5mg/500mg, 500 count bottle, Manufactured In INDIA By: EMCURE PHARMACEUTICALS LTD harmaceuticals Ltd., Hinjwadi, Pune, India, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960,   NDC: 0093-5712-05", "report_date": "20140521", "classification": "Class II", "openfda": {}, "recalling_firm": "Teva Pharmaceuticals USA", "recall_number": "D-1293-2014", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "67811", "termination_date": "20141114", "more_code_info": "", "recall_initiation_date": "20140324", "postal_code": "19044-1220", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Pearl River", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91576", "recalling_firm": "Urban Electric Power", "address_1": "401 N Middletown Rd Bldg 155", "address_2": "", "postal_code": "10965-1298", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0263-2023", "product_description": "Ohm Hand Sanitizer (alcohol (ethanol) 70 % v/v), packaged in a) 2 FL OZ (60 ML), b) 3 FL OZ (88 ML) bottles, c) 10 FL OZ (295 ML) bottles, d)12 FL OZ (355 ML) bottles, e)16 FL OZ (473 ML) bottles,  f) 64 FL OZ (1892 ML) bottles, g) 128 FL OZ (3785 ML) bottles", "product_quantity": "a) 239 bottles, b) 6,352 bottles, c)14,963 bottles, d) 8,117 bottles, e)22 bottles, f)856 bottles, g) 707 bottles", "reason_for_recall": "CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.", "recall_initiation_date": "20230117", "center_classification_date": "20230208", "termination_date": "20240226", "report_date": "20230215", "code_info": "All lots within expiry", "more_code_info": ""}, {"country": "United States", "city": "Birmingham", "address_1": "6801 Cahaba Valley Rd Ste 116", "reason_for_recall": "Lack of Assurance of Sterility", "address_2": "", "product_quantity": "2000 mL in Vials", "code_info": "Lot #: 151203-53; BUD: 05/31/16;  Lot #: 151217-38; BUD: 06/14/16;  Lot #: 160208-36; BUD: 08/06/16", "center_classification_date": "20160708", "distribution_pattern": "U.S. Nationwide, Japan, and New Zealand.", "state": "AL", "product_description": "ZINC SO4 10MG/ML (PF), Vials 2ML, MEDAUS PHARMACY", "report_date": "20160720", "classification": "Class II", "openfda": {}, "recalling_firm": "Medaus, Inc.", "recall_number": "D-1251-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "74466", "termination_date": "20170616", "more_code_info": "", "recall_initiation_date": "20160513", "postal_code": "35242-9609", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA071583"], "brand_name": ["DIAZEPAM"], "generic_name": ["DIAZEPAM"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["0409-3213"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["DIAZEPAM"], "rxcui": ["309845"], "spl_id": ["2d6df2eb-55ce-4d78-b268-99cbb512a687"], "spl_set_id": ["7e7dd743-a87b-4ab3-b6ae-f116cd0c8b0f"], "package_ndc": ["0409-3213-11", "0409-3213-12"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["Q3JTX2Q7TU"]}, "product_type": "Drugs", "event_id": "64720", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Puerto Rico", "recall_number": "D-309-2013", "product_description": "Diazepam Injection, USP 5 mg/mL, 10 mL, Multiple-dose fliptop vial, RX only, HOSPIRA, INC. LAKE FOREST, IL 60045 USA, NDC 0409-3213-12", "product_quantity": "172,350 vials", "reason_for_recall": "Lack of Assurance of Sterility: Loose crimp applied to the fliptop vial.", "recall_initiation_date": "20120828", "center_classification_date": "20130501", "termination_date": "20140918", "report_date": "20130508", "code_info": "Lot 17-100-EV and 17-399-EV", "more_code_info": ""}, {"status": "Terminated", "city": "Allegan", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88384", "recalling_firm": "Perrigo Company PLC", "address_1": "515 Eastern Ave", "address_2": "N/A", "postal_code": "49010-9070", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0351-2022", "product_description": "up&up allergy relief, Fexofenadine Hydrochloride tablets, 24HR, 180mg/antihistamine, packaged as a) 15 count bottle, NDC 11673-571-22 UPC 3 70030 62303 7; b) 30 count bottle, NDC 11673-571-39 UPC 3 70030 62301 3;  Distributed by Target Corp., Mpls., MN 55403, Made in the Czech Republic,", "product_quantity": "7,272 containers", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of specification result obtained for impurity A during stability testing.", "recall_initiation_date": "20210727", "center_classification_date": "20220105", "termination_date": "20221108", "report_date": "20220112", "code_info": "Lot a) 1AE2334, Exp 02/28/2022;  b) 1BR0462, Exp 10/31/2022"}, {"country": "United States", "city": "North Miami Beach", "address_1": "3660 NE 166th St.", "reason_for_recall": "Marketed Without an Approved NDA/ANDA; product found to contain undeclared sibutramine", "address_2": "Apt. 606", "product_quantity": "10 bottles", "code_info": "ALL LOTS", "center_classification_date": "20140414", "distribution_pattern": "Nationwide", "state": "FL", "product_description": "Lidiy capsules Dietary Supplement. Each bottle contains 30 capsules.", "report_date": "20140423", "classification": "Class I", "openfda": {}, "recalling_firm": "B @ B Trade Inc.", "recall_number": "D-1232-2014", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "product_type": "Drugs", "event_id": "66469", "termination_date": "20191002", "recall_initiation_date": "20131007", "postal_code": "33160", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Lake Zurich", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "76728", "recalling_firm": "Fresenius Kabi USA, LLC", "address_1": "3 Corporate Dr", "address_2": "N/A", "postal_code": "60047-8930", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the US", "recall_number": "D-0647-2017", "product_description": "Fluphenazine Decanoate Injection, USP; 25 mg/mL, 5mL vials, Rx only, APP Pharmaceuticals, LLC Schaumburg, IL 60173, NDC 63323-0272-05", "product_quantity": "118,224 vials", "reason_for_recall": "Subpotent Drug", "recall_initiation_date": "20170316", "center_classification_date": "20170405", "termination_date": "20180828", "report_date": "20170412", "code_info": "Lot #: 6111141, Exp. 07/17;  6111222, Exp. 08/17; 6112346, Exp. 01/18;  6112725, Exp. 03/18"}, {"country": "United States", "city": "Deerfield", "address_1": "One Takeda Parkway", "reason_for_recall": "Failed Tablet/Capsule Specifications: Potential tablet defect of broken tablets and/or equatorial splitting of the bilayer tablets into the two drug components.", "address_2": "Attn Supply Chain/Transportation", "product_quantity": "3,619 bottles", "code_info": "Lot # B21642; Exp. 03/17", "center_classification_date": "20150702", "distribution_pattern": "Nationwide", "state": "IL", "product_description": "CONTRAVE (naltrexone HCl and bupropion HCl )extended-release tablets, 8 mg/ 90 mg, 120-count bottle, Rx only, Manufactured for Orexigen Therapeutics, Inc., La Jolia, CA 92037, Distributed by Takeda Pharmaceuticals America, Inc., Deerfield, IL 60015, NDC 64764-890-99.", "report_date": "20150708", "classification": "Class II", "openfda": {}, "recalling_firm": "Takeda Pharmaceuticals North America, Inc.", "recall_number": "D-1206-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "71516", "termination_date": "20180220", "more_code_info": "", "recall_initiation_date": "20150521", "postal_code": "60015", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Corona", "address_1": "595 N Smith Ave Ste B", "reason_for_recall": "Presence of Foreign Tablets/Capsules: Tramodol 50 mg tablet has been found in a bottle of Ciprofloxacin 500 mg", "address_2": "", "product_quantity": "531 bottles", "code_info": "Lot 39661-3 Exp. 07/15", "center_classification_date": "20141023", "distribution_pattern": "Nationwide in US: FL, SC, WA, WV, IN, AL, VA, MS", "state": "CA", "product_description": "Ciprofloxacin 500 mg tablets, 20 count bottle, Rx only, Packaged by Aidarex Pharmacecuticals LLC, MFG: Unique Pharmaceutical Laboratories, Mumbai, India", "report_date": "20141029", "classification": "Class II", "openfda": {}, "recalling_firm": "Aidarex Pharmaceuticals LLC", "recall_number": "D-0042-2015", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "68375", "termination_date": "20141106", "more_code_info": "", "recall_initiation_date": "20140522", "postal_code": "92880-6920", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "78553", "recalling_firm": "KRS Global Biotechnology, Inc", "address_1": "791 Park of Commerce Blvd Ste 600", "address_2": "N/A", "postal_code": "33487-3633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA, Bermuda, and New Zealand", "recall_number": "D-0202-2018", "product_description": "Cyclopentolate HCl/ Phenylephrine HCl/ Tropicamide/ Ketorolac 1%/ 10%/ 1%/ 0.5% Ophthalmic Soln, 5 mL Multi Dose Droptainer, Rx Only, KRS Global Biotechnology, 791 Park of Commerce Blvd, Boca Raton, FL 33487.", "product_quantity": "81 droptainers", "reason_for_recall": "Labeling: Incorrect or Missing Lot and/or Exp Date: Beyond Use Date (BUD) exceed the BUD/EXP of at least one ingredient used to make final product.", "recall_initiation_date": "20171116", "center_classification_date": "20180108", "termination_date": "20200511", "report_date": "20180117", "code_info": "Lot: 10042017@34 BUD: 1/2/2018", "more_code_info": ""}, {"country": "United States", "city": "Baltimore", "address_1": "Harborplace Tower", "reason_for_recall": "Presence of Foreign substance: identified as a dead ant.", "address_2": "111 S Calvert St Fl 21st", "product_quantity": "28,254 bottles", "code_info": "Lot #: F802436, F802437, F802438, F802442, Exp 11/20", "center_classification_date": "20191107", "distribution_pattern": "Product was distributed to major distributors/wholesalers throughout the United States.", "state": "MD", "product_description": "Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, Maryland 21202, United States, Manufactured by: Lupin Limited, Mumbai 400 098 INDIA, NDC 68180-0441-02", "report_date": "20191113", "classification": "Class III", "openfda": {}, "recalling_firm": "Lupin Pharmaceuticals Inc.", "recall_number": "D-0304-2020", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "84196", "termination_date": "20210304", "recall_initiation_date": "20191101", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Augusta", "state": "GA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "64661", "recalling_firm": "Clinical Specialties Compounding Pharmacy", "address_1": "318 Baston Rd", "address_2": "N/A", "postal_code": "30907", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "FL, GA and SC.", "recall_number": "D-651-2013", "product_description": "Medroxyprogesterone 150 mg/ml,Clinical Specialties Compounding Pharmacy, 318 Baston Road, Augusta, GA 30907", "product_quantity": "220ml total", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes", "recall_initiation_date": "20130320", "center_classification_date": "20130703", "termination_date": "20170222", "report_date": "20130710", "code_info": "Lot number CABDDBAB:21, Exp date: 7/30/2013; Lot number CABCBBBA:65, Exp date: 4/9/2013; Lot number CABCBBBA:77, Exp date: 4/9/2013; Lot number CABCBBBA:20 , Exp date: 4/9/2013; Lot number CABCCFBA:42, Exp date: 4/23/2013; Lot number CABCCFBA:59, Exp date: 4/23/2013; Lot number CABCCFBA:76, Exp date: 4/23/2013; Lot number CABCCFBA:85, Exp date: 4/23/2013; Lot number CABCCHBB:28, Exp date: 5/23/2013; Lot number CABCCHBB:46, Exp date: 5/23/2013; Lot number CABCCHBB:87, Exp date: 5/26/2013; Lot number CABCCHBB:30, Exp date: 5/26/2013; Lot number CABCBJBC:92, Exp date: 6/17/2013; Lot number CABCBJBC:93, Exp date: 6/17/2013; Lot number CABCBJBC:31, Exp date: 6/17/2013; Lot number CABDAIAC:21, Exp date: 8/7/2013; Lot number CABDDBAB:05, Exp date: 7/30/2013; Lot number CABDDBAB:03, Exp date: 7/30/2013; Lot numberCABDDBAB:43, Exp date: 7/30/2013; Lot number CABDAIAC:45, Exp date: 8/7/2013 and Lot number CABDAIAC:13, Exp date: 8/7/2013."}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "69494", "recalling_firm": "Hospira Inc.", "address_1": "275 N Field Dr", "address_2": "N/A", "postal_code": "60045-2579", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide, Puerto Rico, and U.S. Virgin Islands.", "recall_number": "D-0280-2015", "product_description": "5% Dextrose and 0.45% Sodium Chloride Injection, USP, 1000 mL container, Rx Only, Manufactured by Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7926-09.", "product_quantity": "823,296 bags", "reason_for_recall": "Lack of Assurance of Sterility: Potential of punctures through the overwrap and primary container which may result in IV bag leaks.", "recall_initiation_date": "20141014", "center_classification_date": "20141125", "termination_date": "20151228", "report_date": "20141203", "code_info": "Lot # 33-095-JT; Exp. 09/15  Lot # 36-030-JT; Exp. 12/15", "more_code_info": ""}, {"status": "Terminated", "city": "Knowlton", "state": "N/A", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "75791", "recalling_firm": "Les Emballages Knowlton Inc.", "address_1": "315  Knowlton Road", "address_2": "Lac Brome", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide", "recall_number": "D-0225-2017", "product_description": "Tom\u0019s of Maine Naturally Dry Natural Powder Antiperspirant Stick, Distributed by: Tom's of Maine, Kennebunk, ME 04043, Made in Canada,  Unit UPC: 077326831953   Case UPC: 10077326831950", "product_quantity": "1,964 cases (35,352 cannisters)", "reason_for_recall": "Labeling: Label Mix Up- Incorrect back label applied to the product.", "recall_initiation_date": "20161122", "center_classification_date": "20161222", "termination_date": "20170516", "report_date": "20161228", "code_info": "Lot: 6282CA3818  Exp: 10/18"}, {"status": "Terminated", "city": "Phoenix", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92707", "recalling_firm": "Central Admixture Pharmacy Services, Inc.", "address_1": "2200 S 43rd Ave", "address_2": "N/A", "postal_code": "85043-3909", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0989-2023", "product_description": "potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL, IV Bag, RX Only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-6060-1", "product_quantity": "7469 bags", "reason_for_recall": "Lack of assurance of sterility. Validation data for decontamination cycles is lacking.", "recall_initiation_date": "20230714", "center_classification_date": "20230801", "termination_date": "20250328", "report_date": "20230809", "code_info": "Lot: 36-239332, Exp. 7/11/2023; 36-241113, Exp. 7/18/2023; 36-242467, 7/25/2023; 36-243530, 36-243659, Exp. 7/30/2023; 36-244888, 8/1/2023, 36-245657, 36-245658, Exp. 8/2/2023; 36-246835, Exp. 8/7/2023; 36-247595, Exp. 8/9/2023; 36-248736, Exp. 8/15/2023;  36-248984, 36-248985, Exp. 8/16/2023; 36-250054, 36-250055, 36-250056, 36-250057, 36-250058, Exp. 8/22/2023; 36-251046, 36-251047, 36-251048, 36-251049, Exp. 8/24/2023; 36-251975, Exp. 8/30/2023; 36-255877, 36-255878, 36-255879, Exp. 9/10/2023."}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-095-2014", "product_description": "Estradiol Pellets 6mg, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "543 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"country": "United States", "city": "Hawthorne", "address_1": "3 Skyline Dr", "reason_for_recall": "Failed Impurities/Degradation Specifications: unknown impurity higher than the specified limit was detected during routine stability testing.", "address_2": "", "product_quantity": "12,432 bottles", "code_info": "Lot # 313342, Exp 12/18", "center_classification_date": "20181120", "distribution_pattern": "Nationwide in the USA", "state": "NY", "product_description": "Children's 24 Hour Allergy (cetirizine hydrochloride) Oral Solution 1 mg/mL, Bubble Gum Flavor, Sugar Free/Dye Free, 4 FL OZ (120 mL) bottle, Dist. by Meijer Distribution, Inc., Grand Rapids, MI 40644, NDC 41250-106-08, UPC 7 13733 88578 2.", "report_date": "20181121", "classification": "Class II", "openfda": {}, "recalling_firm": "Taro Pharmaceuticals U.S.A., Inc.", "recall_number": "D-0276-2019", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "81483", "termination_date": "20201103", "more_code_info": "", "recall_initiation_date": "20181019", "postal_code": "10532-2174", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Orlando", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89938", "recalling_firm": "Olympia Compounding Pharmacy dba Olympia Pharmacy", "address_1": "6700 Conroy Rd Ste 155", "address_2": "", "postal_code": "32835-3515", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0817-2022", "product_description": "PGE-1, Alprostadil 40 mcg/mL, 10ml Multi-Dose vial, Rx Only, Olympia Pharmaceuticals 6700 Convoy Rd., Ste. 155, Orlando, FL 32835. NDC 73198-0028-10.", "product_quantity": "821 vials", "reason_for_recall": "CGMP Deviations: prior to October 1, 2021, environmental and personnel monitoring Out of Action Limit (OOAL) excursions were not being properly investigated", "recall_initiation_date": "20220404", "center_classification_date": "20220427", "termination_date": "20240617", "report_date": "20220504", "code_info": "Lots: I24028 BUD: 9/28/2022,F47C30 BUD: 6/30/2022, F47B30 BUD: 6/30/2022", "more_code_info": ""}, {"country": "United States", "city": "Federal Way", "address_1": "530 S 336th St", "reason_for_recall": "Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due to lack of assurance of sterility.", "address_2": "", "product_quantity": "7 vials total (1/5mL vial and 6/30 mL vials)", "code_info": "Lot # t01-26-2017@98, Exp 4/27/2017; t02-06-2017@108, Exp 4/30/2017.", "center_classification_date": "20170517", "distribution_pattern": "Distributed nationwide in U.S.A.,  Australia and Canada.", "state": "WA", "product_description": "HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5 mL Glass/ Multiple Dose and 30 mL Glass/ Multiple Dose vials,Prepared by Key Compounding Pharmacy", "report_date": "20170524", "classification": "Class II", "openfda": {}, "recalling_firm": "Key Pharmacy and Compounding Center", "recall_number": "D-0725-2017", "initial_firm_notification": "Letter", "product_type": "Drugs", "event_id": "76912", "termination_date": "20170829", "more_code_info": "", "recall_initiation_date": "20170418", "postal_code": "98003-6383", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"country": "United States", "city": "Asheville", "address_1": "752 Biltmore Ave", "reason_for_recall": "Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.", "address_2": "", "product_quantity": "", "code_info": "All lot numbers within expiry.", "center_classification_date": "20140304", "distribution_pattern": "NC", "state": "NC", "product_description": "Voriconazole 0.5mg/ml", "report_date": "20140312", "classification": "Class II", "openfda": {}, "recalling_firm": "Natures Pharmacy & Compounding Center", "recall_number": "D-1144-2014", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "66856", "termination_date": "20140424", "more_code_info": "", "recall_initiation_date": "20131101", "postal_code": "28803-2558", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Racine", "state": "WI", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "96324", "recalling_firm": "Johnson, S C and Son, Inc", "address_1": "1525 Howe St", "address_2": "", "postal_code": "53403-2237", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "", "distribution_pattern": "Nationwide within the United States and Canada", "recall_number": "D-0276-2025", "product_description": "Kids by babyganics SPF 50 mineral sunscreen totally tropical (titanium dioxide 3/5%, zinc oxide 7.25%), packaged in 3 OZ spray bottles, Dist. by KAS Direct LLC, 1525 Howe St. Racine, WI 53403, UPC 813277019923 and UPC 813277019916", "product_quantity": "493,462 units", "reason_for_recall": "Chemical Contamination", "recall_initiation_date": "20250213", "center_classification_date": "20250312", "report_date": "20250319", "code_info": "UPC 813277019916  Lot #: A033 / 5880343A, A054 / 2030633A, A058 / 2050633A, A058 / 2050633B, A058 / 2060633A, A058 / 2070633A, A058 / 2040633A, A059 / 2080633A, Exp. Date Feb-25;  A314 / 4513223A, Exp. Date Nov-25; C054 / 2090774A, C057 / 2100774A, Exp. Date Feb-26; C131 / 3201394A, C131 / 3211394A, C131 / 3211394B, C131 / 3211394C, Exp. Date May-26  UPC 813277019923  Lot #: A060 / 3780693A, A060 / 3780693B, Exp. Date Mar-25; C067 / 2110774A, C067 / 2110774B, C067 / 2110774C, Exp. Date Mar-26; C169 / 7921734A, C169 / 7921734B, Exp. Date Jun-26", "more_code_info": ""}, {"status": "Terminated", "city": "West Columbia", "state": "SC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "91132", "recalling_firm": "Nephron Sterile Compounding Center LLC", "address_1": "4500 12th Street Ext", "address_2": "N/A", "postal_code": "29172-3025", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0064-2023", "product_description": "PF-Labetalol HCl Injection, USP 20 mg/4 mL (5 mg/mL) vial, Rx Only, Nephron 503B Outsourcing Facility 4500 12th Street Extension West Columbia, SC 29172, NDC 69374-946-34, UPC 3 69374 94634 6.", "product_quantity": "34,020 vials", "reason_for_recall": "CGMP Deviations: Potential for cross contamination due to product carry over.", "recall_initiation_date": "20221110", "center_classification_date": "20221117", "termination_date": "20240924", "report_date": "20221123", "code_info": "Lots: LB2001B Exp. 01/07/2023; LB2005B Exp. 03/02/2023"}, {"status": "Terminated", "city": "Newbern", "state": "TN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65479", "recalling_firm": "Main Street Family Pharmacy, LLC", "address_1": "126 East Main Street", "address_2": "N/A", "postal_code": "38059", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "nationwide, specifically:  AK, AL, AZ, CA, CO, CT, DC, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, MN, MO, MS, NC,   NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, SC, TN, TX, UT, VA, WA, WI, and WV", "recall_number": "D-151-2014", "product_description": "HCG Diet Kit, Main Street Compounding Pharmacy, 126 East Main Street, Newbern, TN 38059, 888-658-6200", "product_quantity": "18 units", "reason_for_recall": "The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.", "recall_initiation_date": "20130528", "center_classification_date": "20131203", "termination_date": "20140422", "report_date": "20131211", "code_info": "all codes distributed prior to and including 05/23/2013"}, {"status": "Terminated", "city": "Arlington", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "72269", "recalling_firm": "Lucy's Weight Loss (dba. Waisted With Lucy)", "address_1": "813 Oram St", "address_2": "N/A", "postal_code": "76010-2837", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0879-2016", "product_description": "Pink Bikini Strong Formula capsules, 750 mg, packaged in 30-count plastic bottle, Manufactured and Distributed by: Lucy's Weight Loss System, Arlington, Texas 76010", "product_quantity": "Unknown", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains undeclared sibutramine and phenolphthalein.", "recall_initiation_date": "20150923", "center_classification_date": "20160526", "termination_date": "20221116", "report_date": "20160601", "code_info": "All lots"}, {"country": "United States", "city": "Santa Clarita", "address_1": "21446 Golden Triangle Rd", "reason_for_recall": "Marketed without an Approved NDA/ANDA: Products contain undeclared active pharmaceutical ingredients; desmethyl carbondenafil and dapoxetine.", "address_2": "", "product_quantity": "337 bottles", "code_info": "All lots", "center_classification_date": "20160216", "distribution_pattern": "Nationwide", "state": "CA", "product_description": "Rhino 7 3000, 6 count Bottle, Distributed by Rhino 7, Made in USA", "report_date": "20160224", "classification": "Class I", "openfda": {}, "recalling_firm": "Premiere Sales Group", "recall_number": "D-0672-2016", "initial_firm_notification": "E-Mail", "product_type": "Drugs", "event_id": "72522", "termination_date": "20170601", "more_code_info": "", "recall_initiation_date": "20150930", "postal_code": "91350-2911", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Cherry Hill", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA018140"], "brand_name": ["LORAZEPAM"], "generic_name": ["LORAZEPAM"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "product_ndc": ["0641-6048", "0641-6050", "0641-6049", "0641-6051"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAVENOUS"], "substance_name": ["LORAZEPAM"], "rxcui": ["238100", "238101", "1665188", "1665326"], "spl_id": ["329ddfc8-cf47-4584-a101-4727751e1005"], "spl_set_id": ["4084fa74-9fd2-45ef-9d56-27bfa31d4e46"], "package_ndc": ["0641-6048-01", "0641-6048-25", "0641-6050-01", "0641-6050-10", "0641-6049-01", "0641-6049-25", "0641-6051-01", "0641-6051-10"], "is_original_packager": [true], "nui": ["N0000175694", "M0002356"], "pharm_class_epc": ["Benzodiazepine [EPC]"], "pharm_class_cs": ["Benzodiazepines [CS]"], "unii": ["O26FZP769L"]}, "product_type": "Drugs", "event_id": "90583", "recalling_firm": "Hikma Pharmaceuticals USA Inc.", "address_1": "2 Esterbrook Ln", "address_2": "", "postal_code": "08003-4002", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1309-2022", "product_description": "Lorazepam Injection, USP, 2mg/mL, 1 mL vial,  25 vial per carton, Rx Only, Novaplus, Manufactured by Hikma Berkeley Heights, NJ 07922. Carton NDC# 0641-6048-25, Vial NDC# 0641-6048-01", "product_quantity": "713,550 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.", "recall_initiation_date": "20220711", "center_classification_date": "20220805", "termination_date": "20230914", "report_date": "20220817", "code_info": "Lot # 070088, exp. date 07/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Bridgewater", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "81004", "recalling_firm": "Valeant Pharmaceuticals North America LLC", "address_1": "400 Somerset Corporate Blvd", "address_2": "N/A", "postal_code": "08807-2867", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed throughout the United States", "recall_number": "D-0085-2019", "product_description": "Cortaid Maximum Strength Cream (1% hydrocortisone), 1 OZ (28 g) tube, OTC, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC code 301875521011", "product_quantity": "119,594 tubes", "reason_for_recall": "CGMP deviations: Notice received from supplier of a voluntary recall of all their nasal products and baby oral gels due to the possibility of microbial contamination. No positive results for the firm's products. were obtained. After the firm review, cGMP deviations ere evident.", "recall_initiation_date": "20180824", "center_classification_date": "20181022", "termination_date": "20200306", "report_date": "20181031", "code_info": "Lot #: 170843B, Exp 2/19; 171484D, Exp 4/19; 171791E, 171848E, Exp 5/19; 172359J, 172360J, 173184J, Exp 9/19; 173512P, Exp 12/19; 180180B, Exp 2/20; 181098C, Exp 3/20"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "22 ml total volume", "code_info": "All lots distributed between November 2014 and May 2015;  03232015@6/21/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Morphine 45 mg/ml Solution, Sterile-Preservative Free, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1605-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89646", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide.", "recall_number": "D-1063-2022", "product_description": "MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01", "product_quantity": "363 vials", "reason_for_recall": "cGMP deviations: Temperature abuse", "recall_initiation_date": "20220413", "center_classification_date": "20220609", "termination_date": "20231130", "report_date": "20220615", "code_info": "McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.", "more_code_info": ""}, {"status": "Terminated", "city": "Shenandoah", "state": "IA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "65154", "recalling_firm": "Lloyd Inc. of Iowa", "address_1": "604 W Thomas Ave", "address_2": "N/A", "postal_code": "51601-1744", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "The firm distributed the bulk product to Forest Laboratories, Inc, St. Louis, MO who repackaged the product into 100-tablet bottles and distribution was made to 75 customers Nationwide and Puerto Rico.", "recall_number": "D-439-2013", "product_description": "Lloyd Thyro-Tab 0.112 mg., packaged in 150,000-tablet bulk drums (2/75,000-tablet bags/drum) for repackaging, RX.  The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.", "product_quantity": "7,614,709 tablets", "reason_for_recall": "cGMP deviations; After quality review of stability failures in previous lots, there is insufficient data to determine that other lots are not affected.", "recall_initiation_date": "20130401", "center_classification_date": "20130521", "termination_date": "20140508", "report_date": "20130529", "code_info": "Lot #: HE27211, Exp Apr-13; HE35511, Exp Jul-13; HA04112, Exp Aug-13; HC06212, Exp Sep-12."}, {"status": "Terminated", "city": "San Diego", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "92752", "recalling_firm": "Central Admixture Pharmacy Services Inc", "address_1": "7935 Dunbrook Rd Ste C", "address_2": "N/A", "postal_code": "92126-6322", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-1074-2023", "product_description": "lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1", "product_quantity": "9,517 syringes", "reason_for_recall": "Lack of assurance of sterility: Lack of validation data for sanitization cycles", "recall_initiation_date": "20230717", "center_classification_date": "20230803", "termination_date": "20250321", "report_date": "20230809", "code_info": "Lot: 17-271076, Exp. 7/24/2023; 17-271132, 17-271165, Exp. 7/25/2023; 17-271230, 17-271250, Exp. 7/26/2023; 17-271508, Exp. 7/31/2023; 17-271595, 17-271604, Exp. 8/1/2023;  17-271658, Exp. 8/2/2023; 17-271764, Exp. 8/3/2023; 17-271826, Exp. 8/6/2023; 17-271972, Exp. 8/8/2023; 17-272052, 17-272057, Exp. 8/9/2023; 17-272139, Exp. 8/10/2023; 17-272258, Exp. 8/14/2023; 17-272470, Exp. 8/16/2023; 17-272690, Exp. 8/20/2023; 17-272822, Exp. 8/23/2023; 17-273054, 17-273065, Exp. 8/28/2023; 17-273423, Exp. 9/2/2023; 17-273771, Exp. 9/7/2023."}, {"status": "Terminated", "city": "Chesapeake", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "72746", "recalling_firm": "Sentara Enterprises", "address_1": "535 Independence Pkwy Ste 300", "address_2": "N/A", "postal_code": "23320-5176", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "U.S. Including: VA, NC", "recall_number": "D-0626-2016", "product_description": "GANCICLOVIR in NS, Packaged as a) 320MG in 64ML Homepumps and b) 2440MG in 488ML Homepumps, Rx Only. SENTARA HOME HEALTH SENTARA RX, 535 Independence Pkwy ste.300, Chesapeake, VA 23320-5176.", "product_quantity": "a) 22 Bags, b) 3 Bags", "reason_for_recall": "Lack of Assurance of Sterility: Product sterility cannot be guaranteed.", "recall_initiation_date": "20150918", "center_classification_date": "20160128", "termination_date": "20160629", "report_date": "20160203", "code_info": "All Lots compounded between 11-Sep-15 and 17-Sep-15. Expiries: a) 25-Sep-15, 1-Oct-15, b) 28-Sep-15"}, {"country": "United States", "city": "Knoxville", "address_1": "6216 Highland Place Way Ste 101-A", "reason_for_recall": "Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility", "address_2": "", "product_quantity": "144 pellets", "code_info": "All lots distributed between November 2014 and May 2015;  01082015@8, 7/7/2015; 12052014@62, 6/3/2015; 02242015@10, 8/23/2015; 02122015@29, 7/1/2015; 03032015@19, 8/30/2015; 04232015@13, 10/20/2015", "center_classification_date": "20150915", "distribution_pattern": "Nationwide", "state": "TN", "product_description": "Estradiol 12.5 mg, Sterile Pellet, The Compounding Pharmacy of America, Knoxville, TN", "report_date": "20150923", "classification": "Class II", "openfda": {}, "recalling_firm": "The Compounding Pharmacy of America", "recall_number": "D-1466-2015", "initial_firm_notification": "Telephone", "product_type": "Drugs", "event_id": "71371", "termination_date": "20160210", "more_code_info": "", "recall_initiation_date": "20150602", "postal_code": "37919-4068", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Terminated"}, {"status": "Ongoing", "city": "Basking Ridge", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "82585", "recalling_firm": "Torrent Pharma Inc.", "address_1": "150 Allen Rd Ste 102", "address_2": "N/A", "postal_code": "07920-3856", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and Puerto Rico", "recall_number": "D-1116-2019", "product_description": "LOSARTAN POTASSIUM TABLETS, USP, 100 mg, a) 90-count (NDC: 13668-115-90), b) 1000-count (NDC: 13668-115-10),  per bottle, Rx only, Manufactured by: Torrent Pharmaceuticals LTD, Indrad-382 721, Dist. Mehsana India.  For: Torrent Pharma, Inc, 150 Allen Road, Suite 102, Basking Ridge, NJ", "product_quantity": "121,668 bottles", "reason_for_recall": "CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA)  in the finished product above the interim acceptable daily intake level.", "recall_initiation_date": "20190228", "center_classification_date": "20190410", "report_date": "20190417", "code_info": "Count, lots, expiry: [90-count bottle] Lots 4DU3E014, 4DU3E015, exp 1/31/2021; Lot 4DU3E065, exp 7/31/2021; [1000-count bottle] Lot 4DU3D018, exp 11/30/2020; Lots 4DU3E062, 4DU3E063, exp 6/30/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0555-2021", "product_description": "Chantix (varenicline) Tablets Continuing Month Box Contains: 4 Continuing Weeks (1 mg x 56 tablets) Rx only ; Rx only  Distributed by Pfizer Labs Division of Pfizer, Inc., NY, NY ,10017NDC 0069-0469-56", "product_quantity": "848 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EM1069"}]